episode_id large_stringlengths 9 13 | symbol large_stringclasses 685
values | company_name large_stringclasses 496
values | company_id float64 18.7k 1.87B ⌀ | year int64 2.01k 2.03k ⌀ | quarter int64 1 4 ⌀ | date large_stringdate 2005-10-13 14:45:00 2025-05-15 16:30:00 ⌀ | earnings_date date32 | sector large_stringclasses 11
values | earnings_transcript large_stringlengths 0 226k | press_release_8k_body large_stringlengths 1.68k 684k ⌀ | press_release_ex991 large_stringlengths 1.32k 2.23M ⌀ | press_release_ex992 large_stringlengths 1.14k 279k ⌀ | press_release_sources large_stringclasses 5
values | guidance_mentioned bool 2
classes | beat_mentioned bool 2
classes | price_momentum_30d float64 -0.75 2.55 ⌀ | price_momentum_90d float64 -0.92 3.25 ⌀ | pct_from_52w_high_pt float64 -0.99 0 ⌀ | avg_volume_20d float64 0 1.72B ⌀ | d_minus_1_open float64 0.07 3.5k ⌀ | d_minus_1_high float64 0.07 3.52k ⌀ | d_minus_1_low float64 0.06 3.45k ⌀ | d_minus_1_close float64 0.06 3.48k ⌀ | d_minus_1_volume float64 0 2.7B ⌀ | d_plus_1_open float64 0.08 3.47k ⌀ | d_plus_1_high float64 0.1 3.57k ⌀ | d_plus_1_low float64 0.07 3.47k ⌀ | d_plus_1_close float64 0.09 3.56k ⌀ | d_plus_1_volume float64 0 3.37B ⌀ | d_plus_30_open float64 0.11 3.77k ⌀ | d_plus_30_high float64 0.12 3.92k ⌀ | d_plus_30_low float64 0.1 3.77k ⌀ | d_plus_30_close float64 0.11 3.83k ⌀ | d_plus_30_volume float64 0 2.73B ⌀ | next_qtr_d_minus_1_open float64 0.07 3.5k ⌀ | next_qtr_d_minus_1_high float64 0.07 3.52k ⌀ | next_qtr_d_minus_1_low float64 0.06 3.45k ⌀ | next_qtr_d_minus_1_close float64 0.06 3.48k ⌀ | next_qtr_d_minus_1_volume float64 0 2.36B ⌀ | sentiment_label large_stringclasses 5
values | move_1d float64 -0.54 0.88 ⌀ | move_30d float64 -0.83 1.71 ⌀ | move_next_qtr float64 -0.93 4.61 ⌀ | move_1d_direction large_stringclasses 2
values | gap_open_d1 float64 -0.56 0.77 ⌀ | volume_surge_d1 float64 0.05 30.3 ⌀ | next_qtr_date date32 | xbrl_revenue float64 -3,075,964,000 681B ⌀ | xbrl_cost_of_revenue float64 0 512B ⌀ | xbrl_gross_profit float64 -5,685,000,000 181B ⌀ | xbrl_operating_income float64 -20,727,000,000 123B ⌀ | xbrl_net_income float64 -22,769,000,000 100B ⌀ | xbrl_eps_basic float64 -121.79 860k ⌀ | xbrl_eps_diluted float64 -121.79 120M ⌀ | xbrl_cash_and_cash_equivalents float64 0 462B ⌀ | xbrl_total_assets float64 0 4,358B ⌀ | xbrl_total_liabilities float64 0 4,006B ⌀ | xbrl_net_cash_operating_activities float64 -251,839,000,000 130B ⌀ | xbrl_capital_expenditures float64 -5,984,000,000 100B ⌀ | xbrl_revenue_tag stringclasses 5
values | xbrl_cost_of_revenue_tag stringclasses 2
values | xbrl_gross_profit_tag stringclasses 1
value | xbrl_operating_income_tag stringclasses 1
value | xbrl_net_income_tag stringclasses 2
values | xbrl_eps_basic_tag stringclasses 1
value | xbrl_eps_diluted_tag stringclasses 1
value | xbrl_cash_and_cash_equivalents_tag stringclasses 1
value | xbrl_total_assets_tag stringclasses 1
value | xbrl_total_liabilities_tag stringclasses 1
value | xbrl_net_cash_operating_activities_tag stringclasses 2
values | xbrl_capital_expenditures_tag stringclasses 2
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A_2006_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,006 | 1 | 2006-02-13 14:45:00 | 2006-02-13 | Healthcare | Agilent Technologies Incorporated (NYSE:
A) : Q1 2006 Earnings Release Conference Call February 13, 2006
Operator:
Good day, ladies and gentlemen and welcome to the Q1 2006 Agilent Technology Incorporated Earnings Conference and Analyst Meeting. My name is Jessie and I will be your coordinator for today’s call. At ... | null | null | null | NONE | true | true | 0.058112 | 0.087299 | -0.006371 | 3,490,393.6 | 20.872844 | 21.391684 | 20.872844 | 21.391684 | 7,803,636 | 20.622374 | 21.010013 | 20.479245 | 20.753574 | 5,104,098 | 21.862804 | 22.417426 | 21.719676 | 22.381643 | 5,612,411 | 22.930311 | 22.989948 | 22.172926 | 22.21467 | 4,735,026 | bearish | -0.02983 | 0.046278 | 0.038472 | down | -0.035963 | 1.462327 | 2006-05-15 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2006_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,006 | 2 | 2006-05-15 16:30:00 | 2006-05-15 | Healthcare | Executives:
Hilliard C. Terry - Director, Investor Relations William P. Sullivan - President and Chief Executive Officer Adrian Dillon - Executive Vice President and Chief Financial Officer
Analysts:
Deane Dray - Goldman Sachs Darryl Pardi - Merrill Lynch John Harmon - Needham & Co Ajit Pai - Thomas Weisel Partners Ed... | null | null | null | NONE | true | true | -0.00134 | 0.11194 | -0.057916 | 3,163,247.55 | 22.930311 | 22.989948 | 22.172926 | 22.21467 | 4,735,026 | 21.618306 | 21.82107 | 20.687974 | 20.783392 | 13,497,131 | 18.755743 | 19.053925 | 18.696106 | 19.036036 | 6,152,318 | 16.489548 | 16.507438 | 16.161545 | 16.221182 | 2,291,042 | very bearish | -0.064429 | -0.143087 | -0.269799 | down | -0.026846 | 4.266859 | 2006-08-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2006_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,006 | 3 | 2006-08-14 16:30:00 | 2006-08-14 | Healthcare | Executives:
Hilliard C. Terry - IR William P. Sullivan – President, CEO Adrian Dillon – Vice President Finance and Administration, CFO
Analysts:
Deane Dray – Goldman Sachs John Harmon – Needham & Company Paul Coster – JP Morgan Ajit Pai – Thomas Weisel Partners Edward White – Lehman Brothers Richard Eastman – Robert B... | null | null | null | NONE | true | true | -0.136782 | -0.285151 | -0.312089 | 3,570,051.6 | 16.489548 | 16.507438 | 16.161545 | 16.221182 | 2,291,042 | 18.421773 | 18.994284 | 18.308464 | 18.558937 | 8,751,200 | 18.845194 | 18.892903 | 18.606647 | 18.696102 | 2,713,658 | 21.709803 | 22.247803 | 21.678157 | 22.152861 | 5,801,281 | very bullish | 0.144117 | 0.152573 | 0.365675 | up | 0.135662 | 2.451281 | 2006-11-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2006_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,006 | 4 | 2006-11-14 08:00:00 | 2006-11-14 | Healthcare | Executives:
Hilliard C. Terry, Vice President and Treasurer William P. Sullivan, President, CEO Adrian Dillon, Vice President Finance and Administration, CFO
Analysts:
Ajit Pai, Thomas Weisel Partners Mark Zeff, Goldman Sachs Edward White, Lehman Brothers John Harmon, Needham & Company Richard Eastman, Rob... | null | null | null | NONE | true | false | 0.149331 | 0.197497 | -0.060537 | 3,536,744.25 | 21.709803 | 22.247803 | 21.678157 | 22.152861 | 5,801,281 | 20.886976 | 21.159139 | 20.823682 | 20.975588 | 4,859,029 | 21.361687 | 21.690817 | 21.361687 | 21.557899 | 4,210,776 | 20.792037 | 21.140154 | 20.792037 | 20.849001 | 4,033,230 | very bearish | -0.053143 | -0.026857 | -0.058857 | down | -0.057143 | 1.373871 | 2007-02-15 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2007_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,007 | 1 | 2007-02-15 16:30:00 | 2007-02-15 | Healthcare | TRANSCRIPT SPONSOR:
Executives:
Rodney Gonsalves - Director of IR Bill Sullivan - President and CEO Adrian Dillon - EVP Finance and Administration and CFO
Analysts:
Mark Moskowitz - JP Morgan Ajit Pai - Thomas Weisel Partners Deane Dray - Goldman Sachs John Groberg - Merrill Lynch Richard Eastman - Rober... | null | null | null | NONE | true | false | -0.054807 | 0.058112 | -0.115832 | 3,671,106.1 | 20.792037 | 21.140154 | 20.792037 | 20.849001 | 4,033,230 | 21.342695 | 21.355353 | 20.602157 | 20.741402 | 7,886,118 | 20.241377 | 20.367965 | 20.11479 | 20.159094 | 1,962,093 | 22.735164 | 22.98834 | 22.456671 | 22.918716 | 5,716,142 | neutral | -0.005161 | -0.033091 | 0.099272 | down | 0.02368 | 2.148159 | 2007-05-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2007_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,007 | 2 | 2007-05-14 16:30:00 | 2007-05-14 | Healthcare | TRANSCRIPT SPONSOR:
Executives:
Rodney Gonsalves - Director of IR Bill Sullivan - President and CEO Adrian Dillon - EVP of Finance and Administration and CFO
Analysts:
Ajit Pai - Thomas Weisel Partners John Harmon - Needham & Company Jon Groberg - Merrill Lynch Richard Eastman - Robert W. Baird Deane Dra... | null | null | null | NONE | true | true | 0.074162 | 0.039024 | -0.0344 | 4,174,337.2 | 22.735164 | 22.98834 | 22.456671 | 22.918716 | 5,716,142 | 23.62761 | 24.34916 | 23.62761 | 23.912432 | 11,697,346 | 23.937748 | 24.349159 | 23.874454 | 24.349159 | 2,802,291 | 22.785799 | 23.475701 | 22.785799 | 22.994667 | 4,556,501 | bullish | 0.043358 | 0.062414 | 0.003314 | up | 0.030931 | 2.802204 | 2007-08-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2007_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,007 | 3 | 2007-08-14 16:30:00 | 2007-08-14 | Healthcare | TRANSCRIPT SPONSOR:
Executives:
Rodney Gonsalves - IR Bill Sullivan – President, CEO Adrian Dillon - CFO
Analysts:
John Harmon - Needham Deane Dray - Goldman Sachs Ajit Pai - Thomas Weisel Partners Mark Moskowitz - JP Morgan Dave Egan - Lehman Brothers Richard Eastman - Robert W. Baird William Stein ... | null | null | null | NONE | true | true | -0.054891 | 0.043666 | -0.101187 | 4,302,477.85 | 22.785799 | 23.475701 | 22.785799 | 22.994667 | 4,556,501 | 19.899595 | 20.931286 | 19.716044 | 20.500889 | 11,039,307 | 23.057956 | 23.102261 | 22.92504 | 23.000992 | 1,909,948 | 21.551563 | 21.830058 | 21.386999 | 21.646503 | 2,569,524 | very bearish | -0.10845 | 0.000275 | -0.058629 | down | -0.1346 | 2.565802 | 2007-11-15 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2007_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,007 | 4 | 2007-11-15 16:30:00 | 2007-11-15 | Healthcare | Executives:
Rodney Gonsalves - Director of Investor Relations Bill Sullivan - President and Chief Executive Officer Adrian Dillon - Chief Financial Officer
Analysts:
John Harmon - Needham & Company John Wood - Banc of America Terrance Whalen - Citi Investments Research Mark Moskowitz - JPMorgan Rob Mason - R.W. Baird ... | null | null | null | NONE | true | true | -0.071409 | -0.138539 | -0.153884 | 2,577,436.7 | 21.551563 | 21.830058 | 21.386999 | 21.646503 | 2,569,524 | 22.146528 | 23.393418 | 22.108553 | 23.241512 | 8,877,440 | 22.836427 | 23.076943 | 22.39337 | 22.431345 | 2,982,773 | 20.254036 | 20.443918 | 20.121119 | 20.159094 | 5,405,786 | very bullish | 0.073684 | 0.036257 | -0.068714 | up | 0.0231 | 3.44429 | 2008-02-13 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2008_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,008 | 1 | 2008-02-13 16:30:00 | 2008-02-13 | Healthcare | Executives:
Rodney Gonsalves - IR Bill Sullivan - President and CEO Adrian Dillon - EVP - Finance and Administration and CFO
Analysts:
Jon Wood - Banc of America Securities Rob Mason - Robert W. Baird Terence Whalen - Citi Investment Research Will Stein - Credit Suisse Deane Dray - Goldman Sachs Jon Groberg - Merrill... | null | null | null | NONE | true | true | -0.15044 | -0.135216 | -0.212024 | 5,605,343.8 | 20.254036 | 20.443918 | 20.121119 | 20.159094 | 5,405,786 | 20.684437 | 20.779378 | 19.652747 | 19.962887 | 9,346,329 | 19.405904 | 19.405904 | 18.576755 | 18.760307 | 4,064,825 | 20.50088 | 20.564173 | 20.266691 | 20.399609 | 2,373,664 | neutral | -0.009733 | -0.069387 | 0.011931 | down | 0.02606 | 1.667396 | 2008-05-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2008_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,008 | 2 | 2008-05-14 16:30:00 | 2008-05-14 | Healthcare | Executives:
Rodney Gonsalves - Investor Relations William P. Sullivan - President, Chief Executive Officer, Director Adrian T. Dillon - Chief Financial Officer, Executive Vice President - Finance and Administration
Analysts:
Deane Dray - Goldman Sachs John Wood - Banc of America Securities Mark Moskowitz - JP Morgan R... | null | null | null | NONE | true | false | 0.043379 | -0.103228 | -0.202623 | 3,291,178.55 | 20.50088 | 20.564173 | 20.266691 | 20.399609 | 2,373,664 | 21.627515 | 22.627558 | 21.545232 | 22.368053 | 12,392,152 | 23.38709 | 23.614948 | 23.165562 | 23.614948 | 3,037,854 | 23.285813 | 23.463037 | 22.722498 | 23.133907 | 2,913,991 | very bullish | 0.096494 | 0.157618 | 0.134037 | up | 0.060193 | 3.765263 | 2008-08-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2008_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,008 | 3 | 2008-08-14 16:00:00 | 2008-08-14 | Healthcare | Executives:
Rodney Gonsalves – VP, IR Bill Sullivan – President and CEO Adrian Dillon – CFO and EVP, Finance and Administration
Analysts:
Jon Wood – Banc of America Securities Deane Dray – Goldman Sachs William Stein – Credit Suisse Terence Whalen – Citi Investment Research Rob Mason – Robert W. Baird Ajit Pai – Thoma... | null | null | null | NONE | true | true | 0.027551 | 0.157744 | -0.070448 | 3,133,085.7 | 23.285813 | 23.463037 | 22.722498 | 23.133907 | 2,913,991 | 23.228855 | 23.29215 | 22.7858 | 23.019987 | 3,658,566 | 19.842628 | 20.165427 | 19.494512 | 19.5135 | 3,088,042 | 12.228378 | 13.355009 | 11.424545 | 13.272727 | 5,505,044 | neutral | -0.004924 | -0.156498 | -0.426265 | down | 0.004104 | 1.16772 | 2008-11-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2008_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,008 | 4 | 2008-11-14 08:30:00 | 2008-11-14 | Healthcare | Executives:
Rodney Gonsalves - Vice President of Investor Relations Bill Sullivan - President and CEO Adrian Dillon - Executive Vice President of Finance and Administration and CFO
Analysts:
John Wood - Banc of America John Harmon - Needham & Company William Stein – Credit Suisse Anthony Luscri - JP Morgan Terence Wha... | null | null | null | NONE | true | false | -0.254797 | -0.402394 | -0.451621 | 4,101,312.55 | 12.228378 | 13.355009 | 11.424545 | 13.272727 | 5,505,044 | 12.532186 | 12.70308 | 11.835954 | 12.101788 | 6,550,189 | 11.013136 | 11.07643 | 10.278927 | 10.430832 | 6,224,735 | 11.753676 | 12.01951 | 11.627088 | 11.690382 | 4,232,585 | very bearish | -0.088221 | -0.214115 | -0.119218 | down | -0.055794 | 1.597096 | 2009-02-17 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
A_2009_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,009 | 1 | 2009-02-17 16:45:00 | 2009-02-17 | Healthcare | Executives:
Rodney Gonsalves - Vice President of Investor Relations Bill Sullivan - President and CEO Adrian Dillon - Executive Vice President of Finance and Administration and CFO
Analysts:
Mark Moskowitz – JP Morgan John Wood - Banc of America William Stein – Credit Suisse John Harmon - Needham & Company Ajit Pai –... | null | null | null | NONE | true | false | 0.181702 | -0.315672 | -0.513947 | 5,642,915.15 | 11.753676 | 12.01951 | 11.627088 | 11.690382 | 4,232,585 | 10.127023 | 10.89921 | 10.044741 | 10.158671 | 14,968,246 | 9.240906 | 9.449775 | 9.145965 | 9.329517 | 3,904,474 | 11.816968 | 11.949884 | 11.297957 | 11.424545 | 4,229,929 | very bearish | -0.131023 | -0.201949 | -0.02274 | down | -0.13373 | 2.652573 | 2009-05-14 | 1,166,000,000 | 577,000,000 | null | 24,000,000 | 64,000,000 | 0.18 | 0.18 | 1,362,000,000 | null | null | 17,000,000 | 34,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | null | null | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2009_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,009 | 2 | 2009-05-14 16:45:00 | 2009-05-14 | Healthcare | Executives:
Rodney Gonsalves – Vice President of Investor Relations William P. Sullivan – President and Chief Executive Officer Adrian T. Dillon – Executive Vice President of Finance and Administration, Chief Financial Officer
Analysts:
William Stein - Credit Suisse Jon Wood - BAS-ML Jonathan Groberg - Macquarie Res... | null | null | null | NONE | true | false | 0.174366 | 0.111453 | -0.525 | 4,533,049.95 | 11.816968 | 11.949884 | 11.297957 | 11.424545 | 4,229,929 | 11.405558 | 11.525816 | 10.924524 | 11.171371 | 7,322,864 | 12.108121 | 12.127109 | 11.709369 | 11.956216 | 3,293,408 | 15.551308 | 15.652578 | 15.01964 | 15.21585 | 4,312,970 | bearish | -0.022161 | 0.046538 | 0.331856 | down | -0.001662 | 1.615439 | 2009-08-17 | 1,091,000,000 | 561,000,000 | null | -47,000,000 | -101,000,000 | -0.29 | -0.29 | 1,400,000,000 | null | null | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | null | null | null | null |
A_2009_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,009 | 3 | 2009-08-17 16:45:00 | 2009-08-17 | Healthcare | Executives:
Rodney Gonsalves – Vice President of Investor Relations William P. Sullivan – President and Chief Executive Officer Adrian T. Dillon – Executive Vice President of Finance and Administration, Chief Financial Officer
Analysts:
Analyst for Dean Dray – FBR Capital Markets William Stein - Credit Suisse Jon Wo... | null | null | null | NONE | true | true | 0.219067 | 0.541026 | -0.346739 | 4,853,178 | 15.551308 | 15.652578 | 15.01964 | 15.21585 | 4,312,970 | 15.519666 | 16.456415 | 15.291807 | 16.082981 | 18,696,992 | 17.931157 | 18.20965 | 17.931157 | 18.121038 | 4,520,014 | 17.481764 | 17.526069 | 17.266565 | 17.361506 | 4,887,688 | very bullish | 0.056989 | 0.190932 | 0.141015 | up | 0.019967 | 3.852525 | 2009-11-13 | 1,057,000,000 | 518,000,000 | null | -1,000,000 | -19,000,000 | -0.06 | -0.06 | 1,479,000,000 | 6,573,000,000 | 4,084,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2009_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,009 | 4 | 2009-11-13 08:30:00 | 2009-11-13 | Healthcare | Executives:
Alicia Rodriguez - Vice President of Investor Relations Bill Sullivan - President and CEO Adrian Dillon - Executive Vice President of Finance and Administration and CFO
Analysts:
John Wood - Jefferies William Stein – Credit Suisse Deane Dray – FBR Capital Markets Jon Groberg - Macquarie Capital Mark Dougla... | null | null | null | NONE | true | true | 0.030815 | 0.458266 | -0.066372 | 4,410,445.25 | 17.481764 | 17.526069 | 17.266565 | 17.361506 | 4,887,688 | 17.880515 | 18.671688 | 17.785574 | 18.589405 | 6,200,969 | 18.855246 | 18.988162 | 18.81094 | 18.969175 | 1,865,212 | 18.513461 | 18.741319 | 18.20965 | 18.583084 | 6,982,451 | very bullish | 0.070725 | 0.0926 | 0.070361 | up | 0.029894 | 1.405973 | 2010-02-12 | 4,481,000,000 | 2,189,000,000 | null | 47,000,000 | -31,000,000 | -0.09 | -0.09 | 2,479,000,000 | 7,612,000,000 | 5,106,000,000 | 408,000,000 | 128,000,000 | Revenues | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2010_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,010 | 1 | 2010-02-12 08:30:00 | 2010-02-12 | Healthcare | Executives:
Bill Sullivan – President & CEO Adrian Dillon – EVP Finance & CFO Ron Nersesian – President Electronic Measurement Group Nick Roelofs – President Life Sciences Group Mike McMullen – President Chemical Analysis Group Alicia Rodriguez – VP IR
Analysts:
Deane Dray – FBR Capital Markets William Stein – Credit ... | null | null | null | NONE | true | true | -0.031982 | 0.115925 | -0.075858 | 5,343,156 | 18.513461 | 18.741319 | 18.20965 | 18.583084 | 6,982,451 | 19.140068 | 19.203362 | 18.969175 | 19.146397 | 6,559,556 | 21.08952 | 21.203449 | 20.912296 | 21.083191 | 3,619,282 | 21.532582 | 21.836393 | 21.260418 | 21.640181 | 5,824,767 | bullish | 0.030313 | 0.134537 | 0.16451 | up | 0.029973 | 1.227656 | 2010-05-18 | 1,213,000,000 | 553,000,000 | null | 94,000,000 | 79,000,000 | 0.23 | 0.22 | 2,481,000,000 | 7,574,000,000 | 4,976,000,000 | 30,000,000 | 25,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2010_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,010 | 2 | 2010-05-18 16:30:00 | 2010-05-18 | Healthcare | Executives:
Didier Hirsch - Acting Chief Financial Officer and Vice President Michael McMullen - Senior Vice President and President of Chemical Analysis Group Ronald Nersesian - Senior Vice President and President of Electronic Measurement Group Nicolas Roelofs - Senior Vice President and President of Life Sciences Gr... | null | null | null | NONE | true | true | -0.018093 | 0.108266 | -0.086561 | 5,165,589 | 21.532582 | 21.836393 | 21.260418 | 21.640181 | 5,824,767 | 20.260367 | 20.728742 | 20.254038 | 20.627472 | 7,204,174 | 20.760391 | 20.760391 | 20.266697 | 20.551519 | 3,175,138 | 27.703726 | 28.577183 | 27.627772 | 28.4949 | 6,201,668 | bearish | -0.046798 | -0.050307 | 0.316759 | down | -0.063762 | 1.394647 | 2011-02-14 | 1,271,000,000 | 560,000,000 | null | 154,000,000 | 108,000,000 | 0.31 | 0.31 | 2,646,000,000 | 7,767,000,000 | 5,135,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2011_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,011 | 1 | 2011-02-14 16:30:00 | 2011-02-14 | Healthcare | Executives:
William Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Alicia Rodriguez - Michael McMullen - Senior Vice President and President of Chemical Analysis Group Nicolas Roelofs - Senior Vice President and President of Life Sciences Group Ronald Nersesian - Sen... | null | null | null | NONE | true | true | 0.082472 | 0.362591 | -0.002879 | 5,111,486.3 | 27.703726 | 28.577183 | 27.627772 | 28.4949 | 6,201,668 | 28.349327 | 28.482245 | 26.988508 | 26.994837 | 10,243,286 | 27.589798 | 27.697398 | 26.494814 | 26.792295 | 7,049,695 | 31.545673 | 32.02038 | 31.260851 | 31.855814 | 5,065,373 | very bearish | -0.052643 | -0.059751 | 0.117948 | down | -0.005109 | 2.003974 | 2011-05-13 | 1,519,000,000 | 703,000,000 | null | 211,000,000 | 193,000,000 | 0.56 | 0.54 | 2,638,000,000 | 8,044,000,000 | 4,705,000,000 | 120,000,000 | -38,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2011_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,011 | 2 | 2011-05-13 08:30:00 | 2011-05-13 | Healthcare | Executives:
William Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Alicia Rodriguez - Michael McMullen - Senior Vice President and President of Chemical Analysis Group Nicolas Roelofs - Senior Vice President and President of Life Sciences Group Ronald Nersesian - Se... | null | null | null | NONE | true | true | 0.116212 | 0.201767 | -0.008471 | 4,765,089.9 | 31.545673 | 32.02038 | 31.260851 | 31.855814 | 5,065,373 | 33.033066 | 33.545746 | 32.957116 | 33.115349 | 7,251,706 | 30.545628 | 30.634239 | 29.811418 | 30.083582 | 5,627,509 | 22.121214 | 23.380762 | 21.779426 | 22.918716 | 13,183,979 | bullish | 0.039539 | -0.055633 | -0.280548 | up | 0.036956 | 1.52184 | 2011-08-15 | 1,677,000,000 | 777,000,000 | null | 266,000,000 | 200,000,000 | 0.58 | 0.56 | 2,975,000,000 | 8,649,000,000 | 4,688,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2011_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,011 | 3 | 2011-08-15 16:30:00 | 2011-08-15 | Healthcare | Executives:
William Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Alicia Rodriguez - Michael McMullen - Senior Vice President and President of Chemical Analysis Group Nicolas Roelofs - Senior Vice President and President of Life Sciences Group Ronald Nersesian - Se... | null | null | null | NONE | true | true | -0.291528 | -0.201367 | -0.345563 | 8,507,333.35 | 22.121214 | 23.380762 | 21.779426 | 22.918716 | 13,183,979 | 23.399756 | 24.133964 | 22.804792 | 23.184557 | 10,777,182 | 22.228813 | 23.570644 | 21.918675 | 23.152905 | 9,617,122 | 23.501016 | 23.931413 | 23.418733 | 23.76685 | 3,645,984 | bullish | 0.011599 | 0.010218 | 0.037006 | up | 0.020989 | 1.266811 | 2011-11-15 | 1,691,000,000 | 799,000,000 | null | 281,000,000 | 330,000,000 | 0.95 | 0.92 | 3,101,000,000 | 8,753,000,000 | 4,553,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2011_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,011 | 4 | 2011-11-15 16:30:00 | 2011-11-15 | Healthcare | Executives:
Alicia Rodriguez - William P. Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Ronald S. Nersesian - Senior Vice President and President of Electronic Measurement Group Nicolas H. Roelofs - Senior Vice President and President of Life Sciences Group Didier ... | null | null | null | NONE | true | true | 0.277211 | -0.252439 | -0.321345 | 7,192,122.9 | 23.501016 | 23.931413 | 23.418733 | 23.76685 | 3,645,984 | 23.633937 | 24.931462 | 23.538996 | 24.418781 | 11,574,182 | 21.222437 | 21.380672 | 21.007239 | 21.171803 | 4,477,375 | 27.684745 | 28.007544 | 27.431569 | 27.710062 | 3,659,405 | bullish | 0.02743 | -0.109188 | 0.165912 | up | -0.005592 | 1.609286 | 2012-02-15 | 6,615,000,000 | 3,086,000,000 | null | 1,071,000,000 | 1,012,000,000 | 2.92 | 2.85 | 3,527,000,000 | 9,057,000,000 | 4,741,000,000 | 1,260,000,000 | 188,000,000 | Revenues | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2012_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,012 | 1 | 2012-02-15 16:30:00 | 2012-02-15 | Healthcare | Executives:
Alicia Rodriguez - William P. Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Didier Hirsch - Chief Financial Officer, Principal Accounting Officer and Senior Vice President Ronald S. Nersesian - Chief Operating Officer and Executive Vice President Guy Se... | null | null | null | NONE | true | true | 0.253364 | 0.363014 | -0.208748 | 4,660,568.6 | 27.684745 | 28.007544 | 27.431569 | 27.710062 | 3,659,405 | 27.216363 | 27.817655 | 26.431519 | 27.741701 | 9,901,754 | 29.070878 | 29.115184 | 28.703774 | 28.874668 | 3,186,601 | 25.076475 | 25.558592 | 24.994007 | 25.025724 | 5,398,796 | neutral | 0.001142 | 0.042028 | -0.096872 | up | -0.017817 | 2.124581 | 2012-05-14 | 1,635,000,000 | 761,000,000 | null | 271,000,000 | 230,000,000 | 0.66 | 0.65 | 3,662,000,000 | 9,099,000,000 | 4,600,000,000 | 150,000,000 | 46,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2012_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,012 | 2 | 2012-05-14 16:30:00 | 2012-05-14 | Healthcare | Executives:
Alicia Rodriguez William P. Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Didier Hirsch - Chief Financial Officer and Senior Vice President Nicolas H. Roelofs - Senior Vice President and President of Life Sciences Group Guy Sene - Senior Vice President a... | null | null | null | NONE | true | true | -0.110685 | 0.083852 | -0.285398 | 4,058,435.95 | 25.076475 | 25.558592 | 24.994007 | 25.025724 | 5,398,796 | 25.951893 | 26.370575 | 25.63471 | 25.698147 | 9,783,064 | 24.867132 | 25.266783 | 24.626073 | 24.740259 | 2,873,449 | 25.83643 | 26.046327 | 25.601091 | 25.753744 | 2,788,171 | bullish | 0.026869 | -0.011407 | 0.029091 | up | 0.037009 | 2.41055 | 2012-08-15 | 1,733,000,000 | 815,000,000 | null | 300,000,000 | 255,000,000 | 0.73 | 0.72 | 3,896,000,000 | 9,413,000,000 | 4,688,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2012_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,012 | 3 | 2012-08-15 16:30:00 | 2012-08-15 | Healthcare | Executives:
Alicia Rodriguez William P. Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Didier Hirsch - Chief Financial Officer and Senior Vice President Nicolas H. Roelofs - Senior Vice President and President of Life Sciences Group Lars Holmkvist - President of Dako... | null | null | null | NONE | true | true | 0.040607 | -0.093196 | -0.120805 | 3,222,935.15 | 25.83643 | 26.046327 | 25.601091 | 25.753744 | 2,788,171 | 23.851943 | 24.278098 | 23.381265 | 23.629326 | 17,888,948 | 24.449839 | 25.531127 | 24.424397 | 25.270346 | 9,415,670 | 22.823457 | 22.86172 | 22.606638 | 22.836212 | 9,231,134 | very bearish | -0.08249 | -0.01877 | -0.113286 | down | -0.073846 | 5.550514 | 2012-11-19 | 1,723,000,000 | 833,000,000 | null | 270,000,000 | 243,000,000 | 0.7 | 0.69 | 1,923,000,000 | 9,757,000,000 | 4,884,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2012_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,012 | 4 | 2012-11-19 16:30:00 | 2012-11-19 | Healthcare | Executives:
Alicia Rodriguez William P. Sullivan - Chief Executive Officer, Executive Director and Member of Executive Committee Didier Hirsch - Chief Financial Officer and Senior Vice President Guy Sene - Senior Vice President and President Electronic Measurement Group Nicolas H. Roelofs - Senior Vice President and Pr... | null | null | null | NONE | true | true | -0.081324 | -0.04233 | -0.220405 | 5,209,213.65 | 22.823457 | 22.86172 | 22.606638 | 22.836212 | 9,231,134 | 22.919108 | 23.544059 | 22.829829 | 23.135927 | 14,707,939 | 26.452002 | 26.464755 | 25.878067 | 25.884443 | 6,632,531 | 28.645607 | 28.920493 | 28.562503 | 28.60725 | 2,869,255 | bullish | 0.013125 | 0.133482 | 0.252714 | up | 0.00363 | 2.823447 | 2013-02-14 | 6,858,000,000 | 3,254,000,000 | null | 1,119,000,000 | 1,153,000,000 | 3.31 | 3.27 | 2,351,000,000 | 10,536,000,000 | 5,351,000,000 | 1,228,000,000 | 194,000,000 | Revenues | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2013_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,013 | 1 | 2013-02-14 16:30:00 | 2013-02-14 | Healthcare | Executives:
Alicia Rodriguez William P. Sullivan - Chief Executive Officer, Executive Director and Member of Executive Committee Didier Hirsch - Chief Financial Officer and Senior Vice President Guy Sene - Senior Vice President and President Electronic Measurement Group Michael R. McMullen - Senior Vice President and P... | null | null | null | NONE | true | true | 0.093063 | 0.154096 | -0.02339 | 3,892,493.2 | 28.645607 | 28.920493 | 28.562503 | 28.60725 | 2,869,255 | 27.795376 | 28.281218 | 26.983505 | 27.009075 | 20,489,927 | 27.14333 | 27.296755 | 26.964336 | 27.200865 | 2,582,945 | 27.8428 | 27.926143 | 27.387622 | 27.592773 | 5,951,845 | very bearish | -0.055866 | -0.049162 | -0.035462 | down | -0.02838 | 5.26396 | 2013-05-14 | 1,680,000,000 | 800,000,000 | null | 217,000,000 | 179,000,000 | 0.52 | 0.51 | 2,450,000,000 | 10,653,000,000 | 5,302,000,000 | 245,000,000 | 59,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2013_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,013 | 2 | 2013-05-14 16:30:00 | 2013-05-14 | Healthcare | :
Executives:
Alicia Rodriguez – Vice President of Investor Relations. William P. Sullivan – Chief Executive Officer Didier Hirsch – Chief Financial Officer, Senior Vice President Guy Sene – Senior Vice President and President Electronic Measurement Group
:
:
Lars Holmkvist – Senior Vice President, Agilent, Presid... | null | null | null | NONE | true | true | 0.051552 | 0.030637 | -0.054685 | 4,877,062.8 | 27.8428 | 27.926143 | 27.387622 | 27.592773 | 5,951,845 | 28.785205 | 29.804549 | 28.778794 | 29.285261 | 14,384,022 | 28.12488 | 28.567235 | 27.990249 | 28.522358 | 3,627,391 | 29.862083 | 30.202812 | 29.72708 | 30.164242 | 2,905,324 | very bullish | 0.061338 | 0.033689 | 0.093194 | up | 0.043215 | 2.949321 | 2013-08-14 | 1,732,000,000 | 841,000,000 | null | 213,000,000 | 166,000,000 | 0.48 | 0.48 | 2,519,000,000 | 10,587,000,000 | 5,279,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2013_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,013 | 3 | 2013-08-14 16:30:00 | 2013-08-14 | Healthcare | Executives:
Alicia Rodriguez - Vice President of Investor Relations Bill Sullivan - Chief Executive Officer, Director Didier Hirsch - Chief Financial Officer, Senior Vice President Lars Holmkvist - Senior Vice President and President of Diagnostics and Genomics Group Nick Roelofs - Senior Vice President and President o... | null | null | null | NONE | true | true | 0.076393 | 0.132669 | -0.008825 | 2,909,720.3 | 29.862083 | 30.202812 | 29.72708 | 30.164242 | 2,905,324 | 30.594973 | 30.967848 | 30.119237 | 30.189953 | 9,378,203 | 31.244292 | 31.257152 | 31.006427 | 31.154287 | 2,993,258 | 32.792048 | 33.056238 | 32.64384 | 32.991802 | 2,949,920 | neutral | 0.000852 | 0.032822 | 0.093739 | up | 0.01428 | 3.22306 | 2013-11-14 | 1,652,000,000 | 796,000,000 | null | 236,000,000 | 168,000,000 | 0.5 | 0.49 | 2,330,000,000 | 10,278,000,000 | 5,488,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2013_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,013 | 4 | 2013-11-14 16:30:00 | 2013-11-14 | Healthcare | Executives:
Bill Sullivan - President and CEO Ron Nersesian - President and CEO-Designate, EM Company Didier Hirsch - SVP, CFO Mike McMullen - President, Chemical Analysis Group Lars Holmkvist - SVP and President of Life Sciences and Diagnostics Group Neil Dougherty - VP and CFO-Designate, EM Company Guy Séné - VP and ... | null | null | null | NONE | true | true | -0.007175 | 0.150632 | -0.040243 | 3,092,103.4 | 32.792048 | 33.056238 | 32.64384 | 32.991802 | 2,949,920 | 34.815372 | 35.91725 | 34.596288 | 35.395306 | 15,397,991 | 35.601494 | 35.949453 | 35.485509 | 35.595051 | 2,356,329 | 38.751291 | 39.048386 | 38.53816 | 38.680248 | 3,280,826 | very bullish | 0.072852 | 0.078906 | 0.17242 | up | 0.055273 | 4.979779 | 2014-02-13 | 3,894,000,000 | 3,247,000,000 | null | 951,000,000 | 724,000,000 | 2.12 | 2.1 | 2,675,000,000 | 10,686,000,000 | 5,397,000,000 | 1,152,000,000 | 195,000,000 | Revenues | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2014_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,014 | 1 | 2014-02-13 16:30:00 | 2014-02-13 | Healthcare | Executives:
Bill Sullivan - President and CEO Ron Nersesian - CEO, Keysight Technologies Didier Hirsch - SVP, CFO Mike McMullen - President, Chemical Analysis Group Fred Strohmeier - President of Life Sciences and Diagnostics Group Neil Dougherty - CFO, Keysight Guy Séné - SVP of R&D and Sales Alicia Rodriguez - VP, ... | null | null | null | NONE | true | true | 0.044836 | 0.175634 | -0.021725 | 3,625,055.85 | 38.751291 | 39.048386 | 38.53816 | 38.680248 | 3,280,826 | 36.9106 | 37.311029 | 35.438051 | 35.683475 | 24,946,891 | 35.961203 | 36.432678 | 35.832032 | 36.038704 | 2,009,625 | 36.663297 | 36.889891 | 36.514391 | 36.792778 | 2,048,769 | very bearish | -0.077476 | -0.068292 | -0.048797 | down | -0.045751 | 6.881795 | 2014-05-14 | 1,679,000,000 | 796,000,000 | null | 218,000,000 | 195,000,000 | 0.59 | 0.58 | 2,742,000,000 | 10,638,000,000 | 5,191,000,000 | 194,000,000 | 45,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2014_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,014 | 2 | 2014-05-14 16:30:00 | 2014-05-14 | Healthcare | Executives:
Alicia Rodriguez - Vice President, Investor Relations Bill Sullivan - President and Chief Executive Officer Ron Nersesian - Chief Executive Officer, Keysight Technologies Didier Hirsch - Senior Vice President and Chief Financial Officer Mike McMullen - President, Chemical Analysis Group Fred Strohmeier - Pr... | null | null | null | NONE | true | true | 0.018733 | 0.013477 | -0.069462 | 2,624,779.95 | 36.663297 | 36.889891 | 36.514391 | 36.792778 | 2,048,769 | 35.349043 | 36.352541 | 34.798739 | 35.277828 | 8,024,800 | 37.893383 | 38.113503 | 37.666786 | 37.873959 | 1,474,750 | 35.352057 | 35.670019 | 35.163879 | 35.546726 | 2,406,377 | bearish | -0.041175 | 0.029386 | -0.033867 | down | -0.03924 | 3.057323 | 2014-08-14 | 1,731,000,000 | 832,000,000 | null | 210,000,000 | 139,000,000 | 0.42 | 0.41 | 2,950,000,000 | 11,026,000,000 | 5,397,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2014_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,014 | 3 | 2014-08-14 16:30:00 | 2014-08-14 | Healthcare | Executives:
Alicia Rodriguez - Vice President of Investor Relations William P. Sullivan - Chief Executive Officer, President, Executive Director and Member of Executive Committee Ronald S. Nersesian - Executive Vice President, Chief Executive Officer of Electronic Measurement Group and President of Electronic Measureme... | null | null | null | NONE | true | true | -0.059571 | -0.009569 | -0.100976 | 2,703,557.3 | 35.352057 | 35.670019 | 35.163879 | 35.546726 | 2,406,377 | 38.252654 | 38.324034 | 37.214413 | 37.363663 | 7,799,162 | 37.96064 | 37.96064 | 37.467478 | 37.584278 | 2,266,298 | 37.798425 | 37.916631 | 37.471087 | 37.498367 | 2,697,200 | very bullish | 0.051114 | 0.05732 | 0.054904 | up | 0.076123 | 2.884778 | 2014-11-18 | 1,766,000,000 | 852,000,000 | null | 229,000,000 | 147,000,000 | 0.44 | 0.43 | 2,391,000,000 | 10,380,000,000 | 4,740,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2014_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,014 | 4 | 2014-11-18 17:30:00 | 2014-11-18 | Healthcare | Executives:
Alicia Rodriguez - Vice President, Investor Relations Bill Sullivan - Chief Executive Officer Mike McMullen - President and Chief Operating Officer and CEO-Elect Didier Hirsch - Senior Vice President and CFO Fred Strohmeier - President, Life Sciences and Diagnostics Group Mark Doak - Senior Vice President, ... | null | null | null | NONE | true | false | 0.019154 | 0.020983 | -0.051616 | 2,684,954.15 | 37.798425 | 37.916631 | 37.471087 | 37.498367 | 2,697,200 | 37.116472 | 37.580202 | 37.00736 | 37.098286 | 4,012,100 | 36.807325 | 37.098292 | 36.470896 | 37.007366 | 3,104,100 | 36.432572 | 36.742481 | 36.377881 | 36.596642 | 2,211,900 | bearish | -0.010669 | -0.013094 | -0.024047 | down | -0.010184 | 1.49429 | 2015-02-17 | 4,048,000,000 | 3,388,000,000 | null | 831,000,000 | 504,000,000 | 1.51 | 1.49 | 3,028,000,000 | 10,831,000,000 | 5,530,000,000 | 711,000,000 | 205,000,000 | Revenues | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2015_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,015 | 1 | 2015-02-17 16:30:00 | 2015-02-17 | Healthcare | Executives:
Alicia Rodriguez - VP, IR Bill Sullivan - CEO Mike McMullen - President, COO and CEO Elect Didier Hirsch - SVP and CFO Patrick Kaltenbach - SVP and President, Life Sciences and Applied Markets Mark Doak - SVP and President, Agilent CrossLab Group Jacob Thaysen - SVP and President, Diagnostics and Genomics G... | null | null | null | NONE | true | false | -0.016895 | -0.005354 | -0.063775 | 2,608,910 | 36.432572 | 36.742481 | 36.377881 | 36.596642 | 2,211,900 | 37.480797 | 38.465217 | 37.289384 | 37.863628 | 9,007,200 | 38.328488 | 38.510788 | 38.118843 | 38.474327 | 1,085,700 | 38.422897 | 39.016831 | 38.358935 | 38.952869 | 1,966,100 | bullish | 0.03462 | 0.051308 | 0.064384 | up | 0.024159 | 3.452476 | 2015-05-19 | 1,026,000,000 | 513,000,000 | null | 115,000,000 | 72,000,000 | 0.21 | 0.21 | 2,118,000,000 | 7,519,000,000 | 3,279,000,000 | -20,000,000 | 32,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2015_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,015 | 2 | 2015-05-19 16:30:00 | 2015-05-19 | Healthcare | Executives:
Alicia Rodriguez - Vice President-Investor Relations Michael R. McMullen - President and Chief Executive Officer Didier Hirsch - Chief Financial Officer & Senior Vice President Mark Doak - Senior Vice President and President-Agilent CrossLab Group Patrick Kaltenbach - Senior Vice President & President-LSAG ... | null | null | null | NONE | true | true | 0.016694 | 0.076448 | -0.022024 | 1,918,380 | 38.422897 | 39.016831 | 38.358935 | 38.952869 | 1,966,100 | 38.834085 | 39.144758 | 38.770123 | 38.934597 | 2,652,300 | 36.366982 | 36.604558 | 36.293885 | 36.458359 | 1,865,000 | 35.377092 | 35.477856 | 35.102284 | 35.404575 | 2,632,700 | neutral | -0.000469 | -0.064039 | -0.091092 | down | -0.003049 | 1.382573 | 2015-08-17 | 963,000,000 | 483,000,000 | null | 107,000,000 | 83,000,000 | 0.25 | 0.25 | 2,197,000,000 | 7,412,000,000 | 3,251,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2015_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,015 | 3 | 2015-08-17 20:45:08 | 2015-08-17 | Healthcare | Executives:
Alicia Rodriguez - Vice President, Investor Relations Mike McMullen - President and CEO Didier Hirsch - Senior Vice President and CFO Patrick Kaltenbach - President, Life Sciences and Applied Markets Group Jacob Thaysen - President, Diagnostics and Genomics Group Mark Doak - President, CrossLab Group
Analy... | null | null | null | NONE | true | false | -0.023497 | -0.083134 | -0.111109 | 2,177,030 | 35.377092 | 35.477856 | 35.102284 | 35.404575 | 2,632,700 | 35.825958 | 36.961834 | 35.725194 | 35.743515 | 6,416,900 | 33.114504 | 33.774043 | 33.032061 | 33.453434 | 2,130,100 | 33.761844 | 34.441676 | 33.624039 | 34.294685 | 2,490,200 | neutral | 0.009573 | -0.05511 | -0.031349 | up | 0.011902 | 2.947548 | 2015-11-17 | 1,014,000,000 | 501,000,000 | null | 144,000,000 | 103,000,000 | 0.31 | 0.31 | 2,075,000,000 | 7,251,000,000 | 3,145,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2015_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,015 | 4 | 2015-11-17 16:30:00 | 2015-11-17 | Healthcare | Executives:
Mike McMullen - President, Chief Executive Officer Didier Hirsch - Senior Vice President, Chief Financial Officer Patrick Kaltenbach - President, Agilent’s Life Sciences and Applied Markets Group Jacob Thaysen - President, Agilent’s Diagnostics and Genomics Group Mark Doak - President, Agilent CrossLab Grou... | null | null | null | NONE | true | true | 0.05631 | -0.049787 | -0.138975 | 2,418,575 | 33.761844 | 34.441676 | 33.624039 | 34.294685 | 2,490,200 | 35.305239 | 36.159621 | 35.240931 | 36.141247 | 6,589,600 | 38.171545 | 38.245041 | 37.454968 | 37.464153 | 2,218,800 | 33.015867 | 33.375135 | 32.721083 | 33.365925 | 3,923,600 | very bullish | 0.053844 | 0.092419 | -0.027082 | up | 0.029467 | 2.72458 | 2016-02-16 | 4,038,000,000 | 1,997,000,000 | null | 522,000,000 | 401,000,000 | 1.2 | 1.2 | 2,003,000,000 | 7,479,000,000 | 3,309,000,000 | 491,000,000 | 98,000,000 | Revenues | CostOfRevenue | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2016_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,016 | 1 | 2016-02-16 16:30:00 | 2016-02-16 | Healthcare | Executives:
Alicia Rodriguez - Vice President-Investor Relations Michael R. McMullen - President and Chief Executive Officer Didier Hirsch - Chief Financial Officer & Senior Vice President Jacob Thaysen - Senior Vice President, President, Diagnostics and Genomics Group Mark Doak - Senior Vice President and President-Ag... | null | null | null | NONE | true | true | -0.138747 | 0.027704 | -0.162293 | 2,753,655 | 33.015867 | 33.375135 | 32.721083 | 33.365925 | 3,923,600 | 32.444724 | 35.125421 | 32.011758 | 34.885906 | 5,382,300 | 35.982147 | 36.332201 | 35.549181 | 36.194023 | 1,895,700 | 39.310577 | 39.661648 | 39.162759 | 39.375248 | 2,430,600 | bullish | 0.045555 | 0.08476 | 0.180104 | up | -0.027609 | 1.954602 | 2016-05-16 | 1,028,000,000 | 491,000,000 | null | 155,000,000 | 121,000,000 | 0.37 | 0.37 | 1,931,000,000 | 7,302,000,000 | 3,254,000,000 | 104,000,000 | 38,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2016_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,016 | 2 | 2016-05-16 16:30:00 | 2016-05-16 | Healthcare | Executives:
Alicia Rodriguez - VP-IR Michael McMullen - President and CEO Didier Hirsch - CFO and SVP Jacob Thaysen - SVP, President, Diagnostics and Genomics Group Mark Doak - SVP and President-Agilent CrossLab Group Patrick Kaltenbach - SVP, President, Life Sciences and Applied Markets Group
Analysts:
Dan Leonard - ... | null | null | null | NONE | true | false | 0.057306 | 0.05409 | -0.013426 | 1,721,690 | 39.310577 | 39.661648 | 39.162759 | 39.375248 | 2,430,600 | 41.537088 | 41.888158 | 40.308346 | 41.028961 | 7,130,400 | 41.675675 | 41.92512 | 41.481664 | 41.518616 | 2,029,200 | 44.712605 | 44.962707 | 44.573658 | 44.721867 | 3,176,000 | bullish | 0.041999 | 0.054434 | 0.135786 | up | 0.054904 | 4.141512 | 2016-08-17 | 1,019,000,000 | 489,000,000 | null | 131,000,000 | 91,000,000 | 0.28 | 0.28 | 2,139,000,000 | 7,640,000,000 | 3,475,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2016_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,016 | 3 | 2016-08-17 16:30:00 | 2016-08-17 | Healthcare | Operator:
Good day ladies and gentlemen, and welcome to the Third Quarter 2016 Agilent Technologies Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.
Alicia Rodriguez:
Thank you, Jonathan, and welcome, everyone, to Agilent's Third Quarter Conference Call for Fiscal Yea... | null | null | null | NONE | true | true | 0.103543 | 0.22426 | -0.006993 | 1,645,705 | 44.712605 | 44.962707 | 44.573658 | 44.721867 | 3,176,000 | 43.425037 | 43.851135 | 42.693258 | 43.276829 | 4,660,000 | 42.044847 | 42.044847 | 41.442753 | 41.489067 | 2,592,900 | 43.328607 | 43.393609 | 41.954275 | 42.093567 | 3,443,200 | bearish | -0.032312 | -0.072287 | -0.05877 | down | -0.028998 | 2.831613 | 2016-11-15 | 1,044,000,000 | 502,000,000 | null | 146,000,000 | 124,000,000 | 0.38 | 0.38 | 2,199,000,000 | 7,734,000,000 | 3,388,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2016_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,016 | 4 | 2016-11-15 16:30:00 | 2016-11-15 | Healthcare | Operator:
Good day, ladies and gentlemen, and welcome to the Agilent Technologies Fourth Quarter 2016 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Alicia Rodriguez:
Thank you, Karen, and welcome, everyone, to Agilent's Fourth Quarter Conference Call for Fiscal Yea... | 8-K 1 form8-kxq416pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2016 AGILENT TECHNOLOGIES, INC. (Exact nam... | EX-99.1 2 exhibit991-q416pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Fourth-Quarter 2016 Results Agilent Caps Off 2016 with a Very Strong Quarter Highlights: • GAAP income from continuing operations of $124 million, or $0.38 per share • Non-GAAP income from continuing operations of $... | null | 8K_BODY,EX-99.1 | true | false | -0.038396 | -0.000823 | -0.065544 | 2,204,635 | 43.328607 | 43.393609 | 41.954275 | 42.093567 | 3,443,200 | 42.99432 | 44.387225 | 42.855032 | 42.882889 | 4,026,800 | 42.790031 | 43.430766 | 42.641451 | 43.23576 | 1,338,900 | 47.151301 | 47.393436 | 46.955727 | 47.048859 | 1,568,300 | bullish | 0.018752 | 0.027135 | 0.117721 | up | 0.021399 | 1.826516 | 2017-02-14 | 4,202,000,000 | 2,005,000,000 | null | 615,000,000 | 462,000,000 | 1.42 | 1.4 | 2,289,000,000 | 7,802,000,000 | 3,556,000,000 | 793,000,000 | 139,000,000 | Revenues | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2017_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,017 | 1 | 2017-02-14 16:30:00 | 2017-02-14 | Healthcare | Executives:
Alicia Rodriguez - Agilent Technologies, Inc. Michael R. McMullen - Agilent Technologies, Inc. Didier Hirsch - Agilent Technologies, Inc. Jacob Thaysen - Agilent Technologies, Inc.
Analysts:
Paul Richard Knight - Janney Montgomery Scott LLC Scott Levitt - Evercore Group LLC Derik de Bruin - Bank of America... | 8-K 1 form8-kxq117pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2017 AGILENT TECHNOLOGIES, INC. (Exact nam... | EX-99.1 2 exhibit991-q117pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports First-Quarter 2017 Results Strong Start to 2017, Increasing Core Revenue Growth Guidance Highlights: • GAAP net income of $168 million, or $0.52 per share • Non-GAAP net income of $172 million, or $0.53 per share (1... | null | 8K_BODY,EX-99.1 | true | true | 0.106924 | 0.081919 | -0.007271 | 1,940,920 | 47.151301 | 47.393436 | 46.955727 | 47.048859 | 1,568,300 | 47.626261 | 48.278166 | 47.141989 | 48.07328 | 5,724,500 | 49.758925 | 50.336325 | 49.200151 | 49.405033 | 2,676,900 | 52.365788 | 52.580517 | 52.15106 | 52.403133 | 1,654,400 | bullish | 0.021774 | 0.050079 | 0.113802 | up | 0.012272 | 2.949375 | 2017-05-22 | 1,067,000,000 | 493,000,000 | null | 206,000,000 | 168,000,000 | 0.52 | 0.52 | 2,241,000,000 | 7,872,000,000 | 3,572,000,000 | 116,000,000 | 32,000,000 | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2017_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,017 | 2 | 2017-05-22 16:30:00 | 2017-05-22 | Healthcare | Executives:
Alicia Rodriguez - VP, IR Michael McMullen - CEO, President and Director Didier Hirsch - CFO and SVP Mark Doak - SVP and President, Agilent CrossLab Group Jacob Thaysen - SVP and President, Diagnostics & Genomics Group Patrick Kaltenbach - SVP and President, Life Sciences & Applied Markets Group (LSAG) Bus... | 8-K 1 form8-kxq217pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2017 AGILENT TECHNOLOGIES, INC. (Exact name of ... | EX-99.1 2 exhibit991-q217pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 INVESTOR CONTACT: Alicia Rodriguez +1 408 345 8948 alicia_rodriguez@agilent.com EDITORIAL CONTACT: Stefanie Notaney +1 408 345 8955 stefanie.notaney@agilent.com Agilent Technologies Reports Second-Quarter Fiscal Year 2017 Financial Results Stro... | null | 8K_BODY,EX-99.1 | true | true | 0.056068 | 0.16984 | -0.038541 | 1,826,845 | 52.365788 | 52.580517 | 52.15106 | 52.403133 | 1,654,400 | 55.829459 | 55.997508 | 54.148974 | 54.765152 | 7,510,600 | 56.3056 | 56.51099 | 55.708091 | 55.820126 | 2,247,900 | 55.953797 | 56.178362 | 55.719876 | 55.785374 | 2,409,800 | bullish | 0.045074 | 0.065206 | 0.064543 | up | 0.065384 | 4.111241 | 2017-08-15 | 1,102,000,000 | 510,000,000 | null | 201,000,000 | 164,000,000 | 0.51 | 0.5 | 2,389,000,000 | 8,016,000,000 | 3,641,000,000 | null | null | SalesRevenueNet | CostOfRevenue | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2017_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,017 | 3 | 2017-08-15 00:00:00 | 2017-08-15 | Healthcare | Operator:
Good day, ladies and gentlemen, and welcome to the Q3 2017 Agilent Technologies Incorporated Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.
Alicia Rodriguez:
Thank you, Crystal, and welcome, everyone, to Agilent's Third Quarter Conference Call for Fis... | 8-K 1 form8-kxq317pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2017 AGILENT TECHNOLOGIES, INC. (Exact name ... | EX-99.1 2 exhibit991-q317pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 INVESTOR CONTACT: Alicia Rodriguez +1 408 345 8948 alicia_rodriguez@agilent.com EDITORIAL CONTACT: Stefanie Notaney +1 408 345 8955 stefanie.notaney@agilent.com Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results Stron... | null | 8K_BODY,EX-99.1 | true | false | 0.005227 | 0.133614 | -0.035899 | 1,521,710 | 55.953797 | 56.178362 | 55.719876 | 55.785374 | 2,409,800 | 58.152654 | 58.405285 | 56.852053 | 58.143295 | 6,892,000 | 61.109411 | 61.633398 | 60.969064 | 61.455616 | 1,481,000 | 64.254404 | 64.779463 | 64.029379 | 64.498184 | 1,823,100 | bullish | 0.042268 | 0.101644 | 0.156184 | up | 0.042436 | 4.529115 | 2017-11-20 | 1,114,000,000 | 518,000,000 | null | 201,000,000 | 175,000,000 | 0.55 | 0.54 | 2,563,000,000 | 8,261,000,000 | 3,650,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfRevenue | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2017_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,017 | 4 | 2017-11-20 16:30:00 | 2017-11-20 | Healthcare | Executives:
Alicia Rodriguez - VP, IR Mike McMullen - President and CEO Didier Hirsch - SVP and CFO Patrick Kaltenbach - President, Life Sciences and Applied Markets Group Jacob Thaysen - President, Diagnostics and Genomics Group Mark Doak - President, CrossLab Group
Analysts:
Derik de Bruin - Bank of America Merrill ... | 8-K 1 form8-kxq417pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2017 AGILENT TECHNOLOGIES, INC. (Exact nam... | EX-99.1 2 exhibit991-q417pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results Agilent Caps Stellar Year with Strong Q4 Results Highlights: • GAAP net income of $177 million, or $0.54 per share • Non-GAAP net income of $218 million, or $0.67 pe... | null | 8K_BODY,EX-99.1 | true | true | 0.036618 | 0.126519 | -0.004342 | 1,553,610 | 64.254404 | 64.779463 | 64.029379 | 64.498184 | 1,823,100 | 65.67962 | 66.392199 | 63.47623 | 65.548355 | 5,330,000 | 63.579332 | 63.888745 | 62.969891 | 63.194916 | 1,363,000 | 63.87043 | 64.359063 | 63.57913 | 64.218109 | 1,825,500 | bullish | 0.016282 | -0.020206 | -0.004342 | up | 0.018317 | 3.430719 | 2018-02-14 | 4,472,000,000 | 2,063,000,000 | null | 841,000,000 | 684,000,000 | 2.12 | 2.1 | 2,678,000,000 | 8,426,000,000 | 3,591,000,000 | 889,000,000 | 176,000,000 | Revenues | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2018_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,018 | 1 | 2018-02-14 16:30:00 | 2018-02-14 | Healthcare | Executives:
Alicia Rodriguez - Agilent Technologies, Inc. Michael R. McMullen - Agilent Technologies, Inc. Didier Hirsch - Agilent Technologies, Inc. Jacob Thaysen - Agilent Technologies, Inc. Patrick Kaltenbach - Agilent Technologies, Inc. Mark Doak - Agilent Technologies, Inc.
Analysts:
Ross Muken - Evercore Group L... | 8-K 1 form8-kxq118pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 14, 2018 AGILENT TECHNOLOGIES, INC. (Exact nam... | EX-99.1 2 exhibit991-q118pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports First-Quarter Fiscal Year 2018 Financial Results Excellent Start to 2018; Raising Full Year Guidance Highlights: • Revenue of $1.21 billion, representing growth of 14 percent (core revenue growth of 10 percent (2) v... | null | 8K_BODY,EX-99.1 | true | true | 0.020456 | 0.040426 | -0.0888 | 2,387,020 | 63.87043 | 64.359063 | 63.57913 | 64.218109 | 1,825,500 | 70.420058 | 70.467038 | 66.924426 | 67.67617 | 4,899,100 | 65.702819 | 66.097485 | 64.885297 | 65.684029 | 3,378,100 | 65.161979 | 65.548106 | 64.898281 | 65.406837 | 1,524,200 | very bullish | 0.053849 | 0.022827 | 0.018511 | up | 0.096576 | 2.052392 | 2018-05-14 | 1,211,000,000 | 541,000,000 | null | 239,000,000 | -320,000,000 | -0.99 | -0.99 | 2,887,000,000 | 8,698,000,000 | 4,172,000,000 | 215,000,000 | 60,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2018_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,018 | 2 | 2018-05-14 16:30:00 | 2018-05-14 | Healthcare | Executives:
Alicia Rodriguez - VP of IR Didier Hirsch - Senior VP & CFO Jacob Thaysen - Senior VP and President of Life Sciences & Applied Markets Group Mark Doak - Senior VP & President of Agilent CrossLab Group Michael McMullen - CEO, President & Director Samraat Raha - Senior VP and President of Diagnostics & Genomi... | 8-K 1 form8-kxq218pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2018 AGILENT TECHNOLOGIES, INC. (Exact name of ... | EX-99.1 2 exhibit991-q218pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Second-Quarter Fiscal Year 2018 Financial Results Strong Quarter, Reaffirming Full Year Guidance Highlights: • Revenue of $1.21 billion, representing growth of 9 percent (core revenue growth of 4.3 percent (1) ) • G... | null | 8K_BODY,EX-99.1 | true | true | 0.040433 | 0.02966 | -0.071933 | 2,319,750 | 65.161979 | 65.548106 | 64.898281 | 65.406837 | 1,524,200 | 58.239889 | 60.368318 | 57.166256 | 58.861465 | 14,451,200 | 62.722772 | 62.798116 | 62.129451 | 62.402569 | 4,357,700 | 62.355031 | 63.497341 | 62.355031 | 63.015869 | 3,110,100 | very bearish | -0.100072 | -0.045932 | -0.036555 | down | -0.109575 | 6.229637 | 2018-08-15 | 1,206,000,000 | 563,000,000 | null | 215,000,000 | 205,000,000 | 0.64 | 0.63 | 3,011,000,000 | 8,784,000,000 | 4,167,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2018_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,018 | 3 | 2018-08-15 16:30:00 | 2018-08-15 | Healthcare | Executives:
Alicia Rodriguez - Vice President-Investor Relations Michael McMullen - President, Chief Executive Officer Alicia Rodrigue - Vice President-Investor Relations Didier Hirsch - Senior VP & CFO
Analysts:
Steve Beuchaw - Morgan Stanley Tycho Peterson - JPMorgan. Doug Schenkel - Cowen Brandon Couillard - Jeff... | 8-K 1 form8-kxq318pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2018 AGILENT TECHNOLOGIES, INC. (Exact name ... | EX-99.1 2 exhibit991-q318pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Third-Quarter Fiscal Year 2018 Financial Results Company Tops Third Quarter Revenue and EPS Guidance Raising Full-Year Guidance Highlights: • Revenue of $1.20 billion, representing growth of 8 percent with core reve... | null | 8K_BODY,EX-99.1 | true | true | 0.085895 | 0.051236 | -0.105859 | 2,244,000 | 62.355031 | 63.497341 | 62.355031 | 63.015869 | 3,110,100 | 61.401534 | 61.996288 | 61.184398 | 61.8358 | 3,149,500 | 65.404335 | 65.527068 | 64.724613 | 64.99839 | 1,461,100 | 60.907116 | 62.061306 | 60.907116 | 61.484211 | 2,963,300 | bearish | -0.018727 | 0.031461 | -0.024306 | down | -0.025618 | 1.40352 | 2018-11-19 | 1,203,000,000 | 544,000,000 | null | 225,000,000 | 236,000,000 | 0.74 | 0.73 | 2,131,000,000 | 8,349,000,000 | 3,781,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2018_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,018 | 4 | 2018-11-19 16:30:00 | 2018-11-19 | Healthcare | Executives:
Alicia Rodriguez - Vice President of Investor Relations Mike McMullen - President and Chief Executive Officer, Agilent Robert McMahon - Senior Vice President, Agilent Chief Financial Officer Jacob Thaysen - Senior Vice President and President of Life Sciences & Applied Markets Group Mark Doak - Senior Vice ... | 8-K 1 form8-kxq418pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 19, 2018 AGILENT TECHNOLOGIES, INC. (Exact nam... | EX-99.1 2 exhibit991-q418pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Fourth-Quarter Fiscal Year 2018 Financial Results Agilent delivers outstanding quarter wrapping up an excellent 2018 Highlights: Fourth Quarter • Q4 revenue of $1.29 billion, representing growth of 9 percent with co... | null | 8K_BODY,EX-99.1 | true | true | -0.075533 | 0.026439 | -0.127592 | 2,978,605 | 60.907116 | 62.061306 | 60.907116 | 61.484211 | 2,963,300 | 62.676261 | 64.738666 | 61.427467 | 63.87775 | 8,187,200 | 64.587277 | 65.363043 | 62.259979 | 63.22496 | 2,845,500 | 73.974902 | 74.278388 | 73.415352 | 73.519669 | 2,968,000 | bullish | 0.038929 | 0.028312 | 0.195749 | up | 0.019388 | 2.748669 | 2019-02-20 | 4,914,000,000 | 2,227,000,000 | null | 928,000,000 | 316,000,000 | 0.98 | 0.97 | 2,247,000,000 | 8,541,000,000 | 3,970,000,000 | 1,087,000,000 | 177,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2019_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,019 | 1 | 2019-02-20 16:30:00 | 2019-02-20 | Healthcare | Operator:
Good day, ladies and gentlemen, and welcome to Agilent Technologies First Quarter 2019 Earnings Conference Call. At this time all lines are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be provided at that time. [Operator Instructions] And as a reminder, tod... | 8-K 1 form8-kxq119pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2019 AGILENT TECHNOLOGIES, INC. (Exact nam... | EX-99.1 2 exhibit991-q119pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports First-Quarter Fiscal Year 2019 Financial Results Strong Start to Year as First-Quarter Revenue and EPS Exceed Guidance; Raising Full Year Guidance Highlights: • Revenue of $1.28 billion, representing reported growth... | null | 8K_BODY,EX-99.1 | true | true | 0.184235 | 0.118154 | -0.010215 | 1,820,270 | 73.974902 | 74.278388 | 73.415352 | 73.519669 | 2,968,000 | 73.661911 | 74.524955 | 72.55229 | 73.87056 | 3,570,800 | 77.332224 | 77.464999 | 74.894846 | 74.913811 | 1,435,800 | 71.987873 | 72.13993 | 69.593032 | 70.172729 | 3,547,300 | neutral | 0.004773 | 0.018963 | -0.045524 | up | 0.001935 | 1.961687 | 2019-05-14 | 1,284,000,000 | 577,000,000 | null | 250,000,000 | 504,000,000 | 1.58 | 1.57 | 2,057,000,000 | 8,952,000,000 | 3,916,000,000 | 213,000,000 | 39,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2019_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,019 | 2 | 2019-05-14 16:30:00 | 2019-05-14 | Healthcare | Operator:
Good day, ladies and gentlemen. And welcome to Agilent Technology Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode [Operator instructions]. Later we will conduct a question-and-answer session and instructions will follow at that time. And as a reminder, to... | 8-K 1 form8-kxq219pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2019 AGILENT TECHNOLOGIES, INC. (Exact name of ... | EX-99.1 2 exhibit991-q219pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Second Quarter Fiscal Year 2019 Financial Results Highlights : • Revenue of $1.24 billion represents 3 percent reported growth and 4 percent core revenue (1) growth • GAAP net income of $182 million and EPS of $0.57... | null | 8K_BODY,EX-99.1 | true | true | -0.079486 | 0.126365 | -0.10214 | 2,250,910 | 71.987873 | 72.13993 | 69.593032 | 70.172729 | 3,547,300 | 64.014562 | 66.428414 | 62.950185 | 64.280655 | 14,523,800 | 67.055645 | 67.198197 | 66.418922 | 66.808563 | 1,886,900 | 63.726882 | 65.507916 | 63.336384 | 64.42215 | 3,164,300 | very bearish | -0.083965 | -0.047941 | -0.081949 | down | -0.087757 | 6.452413 | 2019-08-14 | 1,238,000,000 | 569,000,000 | null | 216,000,000 | 182,000,000 | 0.57 | 0.57 | 2,155,000,000 | 9,022,000,000 | 3,897,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2019_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,019 | 3 | 2019-08-14 16:30:00 | 2019-08-14 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies third quarter earnings conference call. [Operator Instructions]. And now I'd like to introduce you to the host for today's conference, Ankur Dhingra, Vice President of Investor Relations. Sir, please go ahead.
Ankur Dhingra:
Thank you, Mike, and welcome... | 8-K 1 form8-kxq319pressrelease.htm 8-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2019 AGILENT TECHNOLOGIES, INC. (Exact name ... | EX-99.1 2 exhibit991-q319pressrelease.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Third Quarter Fiscal Year 2019 Financial Results Highlights : • Revenue of $1.27 billion represents 6 percent reported growth; and up 6 percent (1) on a core basis driven by strength in the pharma, diagnostics, envi... | null | 8K_BODY,EX-99.1 | true | true | -0.107416 | -0.16134 | -0.175719 | 2,667,965 | 63.726882 | 65.507916 | 63.336384 | 64.42215 | 3,164,300 | 68.51759 | 69.193812 | 66.11747 | 66.279381 | 6,701,000 | 73.898804 | 74.336927 | 73.508313 | 74.194061 | 2,673,400 | 75.833116 | 76.797139 | 75.689951 | 76.606247 | 2,640,800 | bullish | 0.028829 | 0.151686 | 0.189129 | up | 0.063572 | 2.511652 | 2019-11-26 | 1,274,000,000 | 582,000,000 | null | 225,000,000 | 191,000,000 | 0.61 | 0.6 | 1,765,000,000 | 8,625,000,000 | 3,878,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2019_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,019 | 4 | 2019-11-26 16:30:00 | 2019-11-26 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there’ll be a question-and-answer session. [Operator Instructions] Thank you. And now, I’d like to introduce you to ... | Document false 0001090872 0001090872 2019-11-25 2019-11-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2019 AGILENT TECHNOLOGIES, INC.... | EX-99.1 2 exhibit991-q419pressre.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports Fourth-Quarter and Fiscal Year 2019 Financial Results Highlights : Fourth-quarter fiscal year 2019 • Revenue of $1.37 billion represents 6% reported growth; and up 4% on a core (1) basis led by strong results from the Ag... | null | 8K_BODY,EX-99.1 | true | true | 0.067571 | 0.170782 | -0.019823 | 1,471,095 | 75.833116 | 76.797139 | 75.689951 | 76.606247 | 2,640,800 | 77.388916 | 77.637075 | 77.016671 | 77.388916 | 1,628,000 | 81.426341 | 81.74132 | 81.216355 | 81.559967 | 649,100 | 81.99045 | 82.124358 | 81.416557 | 82.086098 | 1,965,400 | bullish | 0.010217 | 0.064665 | 0.071533 | up | 0.010217 | 1.106659 | 2020-02-18 | 5,163,000,000 | 2,358,000,000 | null | 941,000,000 | 1,071,000,000 | 3.41 | 3.37 | 1,382,000,000 | 9,452,000,000 | 4,704,000,000 | 1,021,000,000 | 155,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | ProfitLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2020_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,020 | 1 | 2020-02-18 16:30:00 | 2020-02-18 | Healthcare | Operator:
Good afternoon and welcome to the Agilent Technologies first quarter 2020 earnings conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Thank you. And now, I would like to introdu... | Document false 0001090872 0001090872 2020-02-18 2020-02-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 18, 2020 AGILENT TECHNOLOGIES, INC.... | EX-99.1 2 exhibit991-q120pressre.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results Highlights : • Revenue of $1.36 billion represents 5.7% reported growth, up 2.4% on a core (1) basis • GAAP net income of $197 million or 63 cents per share • Non-GAAP (2)... | null | 8K_BODY,EX-99.1 | true | true | -0.001513 | 0.145156 | -0.053177 | 1,893,155 | 81.99045 | 82.124358 | 81.416557 | 82.086098 | 1,965,400 | 81.014838 | 82.105237 | 79.819223 | 81.636559 | 4,741,300 | 65.557925 | 65.605745 | 61.378055 | 62.89888 | 3,430,700 | 79.571668 | 79.571668 | 78.123688 | 78.353828 | 2,748,100 | neutral | -0.005476 | -0.233745 | -0.045468 | down | -0.01305 | 2.504444 | 2020-05-21 | 1,357,000,000 | 634,000,000 | null | 215,000,000 | 197,000,000 | 0.64 | 0.63 | 1,226,000,000 | 9,501,000,000 | 4,653,000,000 | -59,000,000 | 34,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2020_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,020 | 2 | 2020-05-21 16:30:00 | 2020-05-21 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies Second Quarter Earnings Conference call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. And now I'd like to introduce you to... | Document false 0001090872 0001090872 2020-05-21 2020-05-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2020 AGILENT TECHNOLOGIES, INC. (Exa... | EX-99.1 2 exhibit991-q220pressre.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results Highlights : • Revenue of $1.24 billion represents flat reported growth, down 1.7% on a core (1) basis • GAAP net income of $101 million, or 32 cents per share • Non-GAAP (2) net inco... | null | 8K_BODY,EX-99.1 | true | true | 0.103741 | -0.064757 | -0.096227 | 2,094,080 | 79.571668 | 79.571668 | 78.123688 | 78.353828 | 2,748,100 | 81.5087 | 84.06903 | 80.741557 | 81.489525 | 5,063,100 | 84.999174 | 85.411513 | 84.164906 | 84.893692 | 1,245,500 | 93.854949 | 94.8255 | 93.297602 | 93.701202 | 1,989,300 | bullish | 0.04002 | 0.083466 | 0.195873 | up | 0.040264 | 2.417816 | 2020-08-18 | 1,238,000,000 | 581,000,000 | null | 102,000,000 | 101,000,000 | 0.33 | 0.32 | 1,324,000,000 | 9,455,000,000 | 4,687,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2020_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,020 | 3 | 2020-08-18 16:30:00 | 2020-08-18 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies Third Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. And now, I'd like to introduce you to... | Document false 0001090872 0001090872 2020-08-18 2020-08-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 18, 2020 AGILENT TECHNOLOGIES, INC. (... | EX-99.1 2 exhibit991-q320pressre.htm EXHIBIT 99.1 Exhibit Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2020 Financial Results Highlights : • Revenue of $1.26 billion represents decline of 1% reported growth year-over-year, down 3.1% on a core (1) basis • GAAP net income of $199 million, or 64 cents per share ... | null | 8K_BODY,EX-99.1 | true | true | 0.091815 | 0.274152 | -0.018619 | 1,304,930 | 93.854949 | 94.8255 | 93.297602 | 93.701202 | 1,989,300 | 91.510261 | 95.517376 | 90.837599 | 94.133621 | 2,830,800 | 95.373244 | 96.53598 | 94.729417 | 95.709572 | 1,246,400 | 104.584697 | 108.108081 | 104.276643 | 106.75071 | 2,775,400 | neutral | 0.004615 | 0.021434 | 0.139267 | up | -0.023382 | 2.169312 | 2020-11-23 | 1,261,000,000 | 592,000,000 | null | 230,000,000 | 199,000,000 | 0.64 | 0.64 | 1,358,000,000 | 9,546,000,000 | 4,565,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2020_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,020 | 4 | 2020-11-23 16:30:00 | 2020-11-23 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you. And now, I'd like to introduce you t... | a-20201123 0001090872 false 0001090872 2020-11-23 2020-11-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 23, 2020 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q420pressre.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Fourth-Quarter and Fiscal Year 2020 Financial Results; Initiates Fiscal 2021 Guidance Highlights : Fourth-quarter fiscal year 2020 • Revenue of $1.48 billion represents 8% reported growth; and up 6% on a core (1) basis with strong growth... | null | 8K_BODY,EX-99.1 | true | true | 0.048506 | 0.196316 | -0.056255 | 1,594,715 | 104.584697 | 108.108081 | 104.276643 | 106.75071 | 2,775,400 | 114.519474 | 114.519474 | 107.270554 | 110.399239 | 5,559,900 | 113.595308 | 114.452085 | 112.844425 | 112.92144 | 1,202,100 | 122.392365 | 124.002669 | 121.804171 | 123.404831 | 1,278,000 | bullish | 0.034178 | 0.057805 | 0.156009 | up | 0.072775 | 3.486454 | 2021-02-16 | 5,339,000,000 | 2,502,000,000 | null | 846,000,000 | 719,000,000 | 2.33 | 2.3 | 1,441,000,000 | 9,627,000,000 | 4,754,000,000 | 921,000,000 | 119,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2021_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,021 | 1 | 2021-02-16 16:30:00 | 2021-02-16 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies First Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. And now I'd like to introduce you to the host ... | a-20210216 0001090872 false 0001090872 2020-11-23 2020-11-23 0001090872 2021-02-16 2021-02-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February ... | EX-99.1 2 exhibit991-q121pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2021 Financial Results Strong start to 2021, raising full-year guidance Highlights : • Revenue of $1.55 billion represents an increase of 14% reported growth year over year, up 11% on a core (1) basis. • GA... | null | 8K_BODY,EX-99.1 | true | true | 0.092 | 0.243114 | -0.010515 | 1,595,970 | 122.392365 | 124.002669 | 121.804171 | 123.404831 | 1,278,000 | 128.052515 | 132.083077 | 124.957263 | 125.468315 | 4,214,700 | 119.1814 | 119.509249 | 117.76395 | 118.207504 | 2,067,500 | 128.932984 | 129.802139 | 127.986585 | 128.768814 | 1,312,300 | bullish | 0.016721 | -0.042116 | 0.043467 | up | 0.037662 | 2.640839 | 2021-05-25 | 1,548,000,000 | 710,000,000 | null | 328,000,000 | 288,000,000 | 0.94 | 0.93 | 1,329,000,000 | 9,674,000,000 | 4,870,000,000 | 238,000,000 | 41,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2021_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,021 | 2 | 2021-05-25 16:30:00 | 2021-05-25 | Healthcare | Operator:
Good afternoon, and welcome to the Agilent Technologies Second Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] And now I'd like to introduce you to the host f... | a-20210525 0001090872 false 0001090872 2021-05-25 2021-05-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 25, 2021 AGILENT TECHNOLOGIES, INC. (E... | EX-99.1 2 exhibit991-q221pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2021 Financial Results Delivers Strong, Broad-Based Growth Raising Full-Year Outlook on Continued Company Momentum Highlights: • Revenue of $1.525 billion represents an increase of 23% reported growth year... | null | 8K_BODY,EX-99.1 | true | true | 0.015769 | 0.051684 | -0.032577 | 1,310,090 | 128.932984 | 129.802139 | 127.986585 | 128.768814 | 1,312,300 | 131.627371 | 133.269089 | 128.681928 | 128.720551 | 2,498,400 | 142.849008 | 143.244956 | 141.545298 | 141.641861 | 1,426,800 | 154.128116 | 157.154792 | 153.267498 | 156.71965 | 2,154,300 | neutral | -0.000375 | 0.09997 | 0.217062 | down | 0.022199 | 1.907045 | 2021-08-17 | 1,525,000,000 | 708,000,000 | null | 288,000,000 | 216,000,000 | 0.71 | 0.7 | 1,380,000,000 | 10,398,000,000 | 5,588,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2021_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,021 | 3 | 2021-08-17 16:30:00 | 2021-08-17 | Healthcare | Operator:
Good afternoon and welcome to the Agilent Technologies Third Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. [Operator Instructions] And now I'd like to introduce you to the host for today's conference. [Indiscernible], Vice President of Investor Relations... | a-20210817 0001090872 false 0001090872 2021-08-17 2021-08-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2021 AGILENT TECHNOLOGIES, INC.... | EX-99.1 2 exhibit991-q321pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2021 Financial Results Delivers Very Strong Results, Raising Full-Year Guidance Highlights : • Revenue of $1.59 billion represents an increase of 26% reported growth year-over-year, up 21% on a core (1) bas... | null | 8K_BODY,EX-99.1 | true | true | 0.089034 | 0.24174 | -0.002769 | 1,783,175 | 154.128116 | 157.154792 | 153.267498 | 156.71965 | 2,154,300 | 157.812326 | 159.901022 | 156.738969 | 157.638275 | 2,860,900 | 168.188122 | 168.188122 | 165.45156 | 167.559586 | 1,142,000 | 157.824877 | 159.819364 | 157.495696 | 159.073853 | 1,647,600 | neutral | 0.005862 | 0.069168 | 0.015022 | up | 0.006972 | 1.604385 | 2021-11-22 | 1,586,000,000 | 734,000,000 | null | 336,000,000 | 264,000,000 | 0.87 | 0.86 | 1,428,000,000 | 10,491,000,000 | 5,545,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2021_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,021 | 4 | 2021-11-22 16:30:00 | 2021-11-22 | Healthcare | Operator:
Good afternoon and welcome to the Agilent Technologies Fourth Quarter Earnings Conference Call. My name is Bethany, and I will be the operator for today’s call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions]... | a-20211122 0001090872 false 0001090872 2021-11-22 2021-11-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 22, 2021 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q421pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Fourth-Quarter and Fiscal Year 2021 Financial Results Fourth Quarter Caps Off Record-Setting Performance in 2021 Highlights : Fourth-quarter fiscal year 2021 • Revenue of $1.66 billion represents 12% reported growth; and up 11% on a... | null | 8K_BODY,EX-99.1 | true | true | 0.077589 | 0.104354 | -0.083897 | 1,338,775 | 157.824877 | 159.819364 | 157.495696 | 159.073853 | 1,647,600 | 150.931383 | 154.252287 | 146.942438 | 149.856689 | 3,140,600 | 149.537172 | 152.160978 | 149.343537 | 151.79306 | 1,907,900 | 126.51542 | 129.355951 | 126.030687 | 128.018097 | 3,614,100 | very bearish | -0.057943 | -0.04577 | -0.195229 | down | -0.051187 | 2.345876 | 2022-02-22 | 6,319,000,000 | 2,912,000,000 | null | 1,347,000,000 | 1,210,000,000 | 3.98 | 3.94 | 1,484,000,000 | 10,705,000,000 | 5,316,000,000 | 1,485,000,000 | 188,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2022_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,022 | 1 | 2022-02-22 16:30:00 | 2022-02-22 | Healthcare | Operator:
Hello. And welcome to the Q1 2022 Agilent Technologies Earnings Conference Call. My name is Emily, and I will be coordinating the call today. During the presentation you will have the opportunity to ask a question [Audio Gap] [Operator Instructions] I now have the pleasure [Technical Difficulty]
Parmeet Ahuj... | a-20220222 0001090872 false 0001090872 2022-02-22 2022-02-22 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2022 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q122pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2022 Financial Results Strong Start to 2022; Raising Full-Year Guidance Highlights: • Revenue of $1.67 billion represents 8% reported growth; and up 9% on a core (1) basis. • GAAP net income of $283 million... | null | 8K_BODY,EX-99.1 | true | true | -0.114471 | -0.106293 | -0.262747 | 1,855,095 | 126.51542 | 129.355951 | 126.030687 | 128.018097 | 3,614,100 | 125.914345 | 130.267241 | 122.104333 | 122.152809 | 3,938,700 | 130.771356 | 132.409757 | 129.511046 | 132.244949 | 1,346,700 | 122.781516 | 122.80094 | 120.169561 | 122.325157 | 2,037,000 | bearish | -0.045816 | 0.033018 | -0.04447 | down | -0.016433 | 2.12318 | 2022-05-24 | 1,674,000,000 | 764,000,000 | null | 376,000,000 | 283,000,000 | 0.94 | 0.93 | 1,113,000,000 | 10,327,000,000 | 5,173,000,000 | 255,000,000 | 75,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2022_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,022 | 2 | 2022-05-24 16:30:00 | 2022-05-24 | Healthcare | Operator:
Good afternoon and thank you for attending today's Agilent Technologies Inc. Q2 2022 Earnings Conference Call. My name is Selena, and I will be your moderator. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. [Operator Instructions] ... | a-20220524 0001090872 false 0001090872 2022-05-24 2022-05-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2022 AGILENT TECHNOLOGIES, INC. (E... | EX-99.1 2 exhibit991-q222pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2022 Financial Results Delivers solid results; increases full-year core growth and EPS forecast Highlights: • Revenue of $1.61 billion represents 5% reported growth; and up 7% on a core (1) basis. • GAAP n... | null | 8K_BODY,EX-99.1 | true | true | -0.065915 | -0.156058 | -0.295532 | 2,116,510 | 122.781516 | 122.80094 | 120.169561 | 122.325157 | 2,037,000 | 123.519482 | 123.762229 | 115.722443 | 116.887627 | 3,524,500 | 111.275301 | 115.304906 | 110.954873 | 115.159256 | 1,801,600 | 129.642592 | 130.946018 | 129.049239 | 130.245667 | 1,291,100 | bearish | -0.044451 | -0.058581 | 0.06475 | down | 0.009764 | 1.665241 | 2022-08-16 | 1,607,000,000 | 746,000,000 | null | 360,000,000 | 274,000,000 | 0.92 | 0.91 | 1,186,000,000 | 10,455,000,000 | 5,333,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2022_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,022 | 3 | 2022-08-16 16:30:00 | 2022-08-16 | Healthcare | Operator:
Good afternoon. Thank you for attending today’s Agilent Technologies Q3 ‘22 Earnings Call. My name is Tina, and I will be your moderator for today’s call. [Operator Instructions] I would now like to pass the conference over to our host, Parmeet Ahuja with Agilent. Please go ahead.
Parmeet Ahuja:
Thank you, H... | a-20220816 0001090872 false 0001090872 2022-08-16 2022-08-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2022 AGILENT TECHNOLOGIES, INC.... | EX-99.1 2 exhibit991-q322pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2022 Financial Results Delivers excellent results; again raises full-year guidance Highlights: • Revenue of $1.72 billion represents 8% reported growth year-over-year; and up 13% on a core (1) basis. • GAAP... | null | 8K_BODY,EX-99.1 | true | true | 0.123228 | 0.006583 | -0.249918 | 1,290,490 | 129.642592 | 130.946018 | 129.049239 | 130.245667 | 1,291,100 | 144.777936 | 144.933573 | 136.208377 | 138.406693 | 4,110,100 | 130.158149 | 131.811751 | 129.03954 | 129.525894 | 1,446,500 | 142.923839 | 144.171074 | 140.458627 | 142.446396 | 1,283,400 | very bullish | 0.062659 | -0.005526 | 0.093675 | up | 0.111576 | 3.184914 | 2022-11-21 | 1,718,000,000 | 779,000,000 | null | 411,000,000 | 329,000,000 | 1.1 | 1.1 | 1,071,000,000 | 10,484,000,000 | 5,393,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2022_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,022 | 4 | 2022-11-21 16:30:00 | 2022-11-21 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q4 2022 Earnings Conference Call. My name is Bo and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, Vice President of Investor Relations. Mr. Ahuja, please go ahead.
Parmeet Ahuja:
... | a-20221121 0001090872 false 0001090872 2022-11-21 2022-11-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2022 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q422pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Fourth-Quarter and Fiscal Year 2022 Financial Results Outstanding fourth quarter caps off another strong year of performance in 2022 Fourth-quarter fiscal year 2022 • Revenue of $1.85 billion represents 11% reported growth year-over... | null | 8K_BODY,EX-99.1 | true | true | 0.147128 | 0.263747 | -0.111985 | 1,250,540 | 142.923839 | 144.171074 | 140.458627 | 142.446396 | 1,283,400 | 148.088116 | 153.408304 | 148.088116 | 152.843155 | 3,512,500 | 145.125961 | 146.421904 | 144.102846 | 146.246506 | 1,248,100 | 139.428755 | 140.287488 | 138.384593 | 138.745651 | 1,149,600 | very bullish | 0.072987 | 0.026677 | -0.02598 | up | 0.039606 | 2.808787 | 2023-02-28 | 6,848,000,000 | 3,126,000,000 | null | 1,618,000,000 | 1,254,000,000 | 4.19 | 4.18 | 1,053,000,000 | 10,532,000,000 | 5,227,000,000 | 1,312,000,000 | 291,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2023_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,023 | 1 | 2023-02-28 08:30:00 | 2023-02-28 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q1 2023 Earnings Call. My name is Bill and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, to begin the conference. Parmeet, please go ahead.
Parmeet Ahuja:
Thank you, Bill and welc... | a-20230228 0001090872 false 0001090872 2023-02-28 2023-02-28 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 28, 2023 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q123pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2023 Financial Results Delivers excellent start to the year; raises full-year guidance Highlights: • Revenue of $1.76 billion represents 5% reported growth year-over-year; and up 10% on a core (1) basis. • ... | null | 8K_BODY,EX-99.1 | true | true | -0.091444 | 0.090625 | -0.111494 | 1,252,075 | 139.428755 | 140.287488 | 138.384593 | 138.745651 | 1,149,600 | 135.232654 | 136.608599 | 132.958932 | 134.188492 | 3,132,800 | 132.002613 | 132.266081 | 130.099718 | 131.241455 | 1,468,200 | 125.756781 | 126.822181 | 125.39512 | 126.177071 | 1,764,500 | bearish | -0.032845 | -0.054086 | -0.090587 | down | -0.02532 | 2.502087 | 2023-05-23 | 1,756,000,000 | 788,000,000 | null | 426,000,000 | 352,000,000 | 1.19 | 1.19 | 1,250,000,000 | 10,919,000,000 | 5,310,000,000 | 296,000,000 | 76,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2023_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,023 | 2 | 2023-05-23 16:30:00 | 2023-05-23 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies' Q2 2023 Earnings Call. My name is Sarah, and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, to begin. Please go ahead.
Parmeet Ahuja:
Thank you, Sarah, and welcome, everyone, to A... | a-20230523 0001090872 false 0001090872 2023-05-23 2023-05-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2023 AGILENT TECHNOLOGIES, INC. (E... | EX-99.1 2 exhibit991-q223pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Highlights: • Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up... | null | 8K_BODY,EX-99.1 | true | true | -0.064701 | -0.182523 | -0.191981 | 1,674,320 | 125.756781 | 126.822181 | 125.39512 | 126.177071 | 1,764,500 | 112.6005 | 118.357592 | 110.723827 | 118.25985 | 6,850,400 | 116.158377 | 116.265895 | 114.526062 | 116.001991 | 1,736,000 | 122.833777 | 125.350582 | 122.598747 | 124.028526 | 1,582,400 | very bearish | -0.062747 | -0.080641 | -0.017028 | down | -0.107599 | 4.091452 | 2023-08-15 | 1,717,000,000 | 793,000,000 | null | 383,000,000 | 302,000,000 | 1.02 | 1.02 | 1,175,000,000 | 10,792,000,000 | 5,011,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2023_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,023 | 3 | 2023-08-15 16:30:00 | 2023-08-15 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q3 2023 Earnings Conference Call. My name is Bo and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja. Parmeet, please go ahead.
Parmeet Ahuja:
Thank you, Bo, and welcome, everyone, to... | a-20230815 0001090872 false 0001090872 2023-08-15 2023-08-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 15, 2023 AGILENT TECHNOLOGIES, INC.... | EX-99.1 2 exhibit991-q323pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions Highlights: • Reported revenue of $1.67 billion declined 2.7% year-over-year, and decreased 2.3% on a cor... | null | 8K_BODY,EX-99.1 | true | true | 0.053222 | -0.081891 | -0.20574 | 2,140,785 | 122.833777 | 125.350582 | 122.598747 | 124.028526 | 1,582,400 | 119.464995 | 121.090639 | 117.878531 | 118.848038 | 3,388,800 | 111.434724 | 112.923259 | 109.368397 | 112.502159 | 1,815,800 | 111.845833 | 112.326656 | 109.961777 | 111.031372 | 2,700,800 | bearish | -0.041769 | -0.092933 | -0.104792 | down | -0.036794 | 1.582971 | 2023-11-20 | 1,672,000,000 | 1,014,000,000 | null | 133,000,000 | 111,000,000 | 0.38 | 0.38 | 1,329,000,000 | 10,675,000,000 | 5,117,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2023_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,023 | 4 | 2023-11-20 16:30:00 | 2023-11-20 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q4 2023 Earnings Conference Call. My name is Bo and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, Vice President, Investor Relations. Please go ahead, sir.
Parmeet Ahuja:
Thank y... | a-20231120 0001090872 false 0001090872 2023-11-20 2023-11-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2023 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q423pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Fourth-Quarter Fiscal Year 2023 Financial Results Revenue at the high end of guidance and EPS exceeds guidance Fourth-quarter fiscal year 2023 • Revenue of $1.69 billion, down 8.7% reported and 9.7% core (1) from the fourth quarter ... | null | 8K_BODY,EX-99.1 | true | true | 0.022686 | -0.050037 | -0.288972 | 2,131,000 | 111.845833 | 112.326656 | 109.961777 | 111.031372 | 2,700,800 | 119.185793 | 122.345503 | 118.960104 | 121.599731 | 6,085,800 | 137.172598 | 138.595461 | 135.553498 | 135.592743 | 2,120,900 | 129.531245 | 130.651791 | 128.59746 | 129.246201 | 1,677,500 | very bullish | 0.095184 | 0.221211 | 0.164051 | up | 0.073442 | 2.855842 | 2024-02-27 | 6,833,000,000 | 3,368,000,000 | null | 1,350,000,000 | 1,240,000,000 | 4.22 | 4.19 | 1,590,000,000 | 10,763,000,000 | 4,918,000,000 | 1,772,000,000 | 298,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2024_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,024 | 1 | 2024-02-27 16:30:00 | 2024-02-27 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q1 2024 Earnings Call. My name is Regina and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, to begin. Please go ahead.
Parmeet Ahuja:
Thank you, Regina and welcome, everyone, to Ag... | a-20240227 0001090872 false 0001090872 2024-02-27 2024-02-27 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2024 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q124pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2024 Financial Results Revenue and earnings exceed Q1 guidance Full-year outlook maintained Highlights • Revenue of $1.66 billion, down 5.6% reported and 6.4% core (1) from the first quarter of 2023. • GAAP... | null | 8K_BODY,EX-99.1 | true | true | 0.013957 | 0.181277 | -0.089347 | 1,459,740 | 129.531245 | 130.651791 | 128.59746 | 129.246201 | 1,677,500 | 137.493048 | 137.493048 | 134.023286 | 134.672012 | 2,537,100 | 145.022305 | 145.159915 | 142.879513 | 143.026947 | 2,176,500 | 148.487203 | 148.851475 | 145.415451 | 145.917572 | 1,366,900 | bullish | 0.04198 | 0.106624 | 0.128989 | up | 0.063807 | 1.738049 | 2024-05-29 | 1,658,000,000 | 750,000,000 | null | 384,000,000 | 348,000,000 | 1.19 | 1.18 | 1,748,000,000 | 10,948,000,000 | 4,760,000,000 | 485,000,000 | 90,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2024_Q2 | A | Agilent Technologies, Inc. | 154,924 | 2,024 | 2 | 2024-05-29 16:30:00 | 2024-05-29 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q2 2024 Earnings Call. My name is Regina, and I will be coordinating your call today. [Operator Instructions]. I will now hand you over to your host, Parmeet Ahuja, to begin. Please go ahead.
Parmeet Ahuja:
Thank you, and welcome, everyone, to Agilent... | a-20240529 0001090872 false 0001090872 2024-05-29 2024-05-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2024 AGILENT TECHNOLOGIES, INC. (E... | EX-99.1 2 exhibit991-q224pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results Full-year outlook revised to reflect slower market recovery Announces plan to repurchase $0.75 billion of its common stock by end of fiscal year Board of directors authorizes new $2.... | null | 8K_BODY,EX-99.1 | true | true | 0.056982 | 0.137903 | -0.04596 | 1,311,400 | 148.487203 | 148.851475 | 145.415451 | 145.917572 | 1,366,900 | 123.361919 | 133.089089 | 123.361919 | 129.387253 | 5,138,500 | 129.623539 | 130.982183 | 126.404113 | 127.624939 | 9,817,600 | 138.682162 | 139.609327 | 137.528108 | 137.84375 | 1,227,700 | very bearish | -0.113285 | -0.125363 | -0.055331 | down | -0.154578 | 3.918332 | 2024-08-21 | 1,573,000,000 | 717,000,000 | null | 363,000,000 | 308,000,000 | 1.05 | 1.05 | 1,671,000,000 | 10,856,000,000 | 4,642,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2024_Q3 | A | Agilent Technologies, Inc. | 154,924 | 2,024 | 3 | 2024-08-21 16:30:00 | 2024-08-21 | Healthcare | Operator:
Ladies and gentlemen, welcome to the Agilent Technologies Q3 2024 Earnings Call. My name is Regina and I will be coordinating your call today. [Operator Instructions] I will now hand you over to your host, Parmeet Ahuja, to begin. Please go ahead.
Parmeet Ahuja:
Thank you and welcome, everyone, to Agilent's ... | a-20240821 0001090872 false 0001090872 2024-08-21 2024-08-21 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2024 AGILENT TECHNOLOGIES, INC.... | EX-99.1 2 exhibit991-q324pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results Delivers better-than-expected performance; raises mid-point of guidance Highlights • Revenue of $1.58 billion, down 5.6% reported and 4.4% core (1) from the third quarter of 2023. • G... | null | 8K_BODY,EX-99.1 | true | true | 0.114256 | -0.034418 | -0.098749 | 1,555,455 | 138.682162 | 139.609327 | 137.528108 | 137.84375 | 1,227,700 | 143.396962 | 143.465999 | 136.265571 | 138.307343 | 2,634,500 | 139.283856 | 139.471252 | 135.999276 | 138.179123 | 2,613,600 | 130.50553 | 132.698735 | 129.912766 | 132.224518 | 2,067,800 | neutral | 0.003363 | 0.002433 | -0.040765 | up | 0.040286 | 1.693717 | 2024-11-25 | 1,578,000,000 | 723,000,000 | null | 333,000,000 | 282,000,000 | 0.97 | 0.97 | 1,779,000,000 | 10,996,000,000 | 5,093,000,000 | null | null | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | null | null |
A_2024_Q4 | A | Agilent Technologies, Inc. | 154,924 | 2,024 | 4 | 2024-11-25 16:30:00 | 2024-11-25 | Healthcare | Operator:
Good afternoon. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Agilent Technologies Inc. Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there wil... | a-20241125 0001090872 false 0001090872 2024-11-25 2024-11-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2024 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q424pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results Delivers solid results in Q4; initiates FY25 guidance Fourth-quarter fiscal year 2024 • Revenue of $1.70 billion, up 0.8% reported and down 0.3% core (1) from the fourth quarter of 2... | null | 8K_BODY,EX-99.1 | true | true | -0.069392 | 0.015784 | -0.135489 | 2,005,120 | 130.50553 | 132.698735 | 129.912766 | 132.224518 | 2,067,800 | 125.486841 | 133.182815 | 124.647102 | 132.748123 | 3,443,900 | 133.380396 | 134.338689 | 133.340886 | 134.190506 | 556,600 | 133.7655 | 134.883929 | 131.835479 | 132.805435 | 2,607,000 | neutral | 0.00396 | 0.014869 | 0.004393 | up | -0.050956 | 1.717553 | 2025-02-26 | 6,510,000,000 | 2,975,000,000 | null | 1,488,000,000 | 1,289,000,000 | 4.44 | 4.43 | 1,329,000,000 | 11,846,000,000 | 5,948,000,000 | 1,751,000,000 | 378,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
A_2025_Q1 | A | Agilent Technologies, Inc. | 154,924 | 2,025 | 1 | 2025-02-26 16:30:00 | 2025-02-26 | Healthcare | Operator:
Good afternoon. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to the First Quarter 2025 Agilent Technologies Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there w... | a-20250226 0001090872 false 0001090872 2025-02-26 2025-02-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2025 AGILENT TECHNOLOGIES, IN... | EX-99.1 2 exhibit991-q125pressrelease.htm EX-99.1 Document Exhibit 99.1 Agilent Reports First-Quarter Fiscal Year 2025 Financial Results Delivers solid Q1 results, confirms core growth and EPS for 2025 fiscal year First-quarter fiscal year 2025 • Revenue of $1.68 billion for the first quarter ended Jan. 31, 2025, repre... | null | 8K_BODY,EX-99.1 | true | true | -0.023933 | -0.06809 | -0.13169 | 1,599,010 | 133.7655 | 134.883929 | 131.835479 | 132.805435 | 2,607,000 | 127.460765 | 129.974753 | 124.521189 | 125.778183 | 3,469,100 | 117.988803 | 118.434198 | 115.168 | 115.494621 | 1,772,900 | null | null | null | null | null | very bearish | -0.052914 | -0.130347 | null | down | -0.040244 | 2.16953 | null | 1,681,000,000 | 782,000,000 | null | 376,000,000 | 318,000,000 | 1.12 | 1.11 | 1,467,000,000 | 11,914,000,000 | 5,887,000,000 | 431,000,000 | 97,000,000 | RevenueFromContractWithCustomerExcludingAssessedTax | CostOfGoodsAndServicesSold | null | OperatingIncomeLoss | NetIncomeLoss | EarningsPerShareBasic | EarningsPerShareDiluted | CashAndCashEquivalentsAtCarryingValue | Assets | Liabilities | NetCashProvidedByUsedInOperatingActivities | PaymentsToAcquirePropertyPlantAndEquipment |
AA_2006_Q4 | AA | null | null | 2,006 | 4 | 2007-01-09 17:00:00 | 2007-01-09 | Basic Materials | Executives:
Tony Thene - Director, Investor Relations Charles D. McLane - Vice President, Chief Financial Officer Alain Belda - Chairman, Chief Executive Officer
Analysts:
Michael Gambardella - J.P. Morgan David Gagliano - Credit Suisse Kuni Chen - Banc of America Securities David Lipschitz - Merrill Lynch Hongyu Cai ... | null | null | null | NONE | true | true | -0.019427 | -0.002697 | -0.217524 | 2,311,656.2 | 56.661605 | 56.956003 | 55.503644 | 55.896172 | 4,276,363 | 58.035457 | 59.585947 | 57.328903 | 59.330807 | 9,689,305 | 63.807741 | 64.636414 | 63.531518 | 64.399651 | 5,391,303 | 68.681079 | 69.312447 | 68.404857 | 68.799461 | 2,938,785 | very bullish | 0.061447 | 0.15213 | 0.230844 | up | 0.038272 | 4.191499 | 2007-04-10 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2007_Q1 | AA | null | null | 2,007 | 1 | 2007-04-10 17:00:00 | 2007-04-10 | Basic Materials | TRANSCRIPT SPONSOR:
Executives:
Tony Thene - Director, Investor Relations Charles McLane - Vice President, Chief Financial Officer Alain Belda - Chairman, Chief Executive Officer
Analysts:
Michael Gambardella - JP Morgan David Gagliano - Credit Suisse Kuni Chen - Banc of America Securities Ross Clifford – ... | null | null | null | NONE | true | true | -0.005986 | 0.147194 | -0.036894 | 3,479,159.35 | 68.681079 | 69.312447 | 68.404857 | 68.799461 | 2,938,785 | 70.338428 | 70.555466 | 68.898119 | 69.213806 | 6,970,620 | 76.23575 | 76.33489 | 74.47113 | 74.609917 | 6,486,350 | 82.421873 | 83.274449 | 82.283086 | 82.600319 | 3,882,730 | neutral | 0.006023 | 0.084455 | 0.200595 | up | 0.022369 | 2.003536 | 2007-07-09 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2007_Q2 | AA | null | null | 2,007 | 2 | 2007-07-09 17:00:00 | 2007-07-09 | Basic Materials | null | null | null | NONE | false | false | 0.031955 | 0.238969 | -0.028904 | 4,429,280 | 82.421873 | 83.274449 | 82.283086 | 82.600319 | 3,882,730 | 84.424428 | 84.662355 | 82.40205 | 82.600319 | 6,771,203 | 72.712848 | 74.903597 | 72.712848 | 73.867973 | 6,724,761 | 76.696028 | 77.014685 | 75.401496 | 76.277794 | 3,056,970 | neutral | 0 | -0.105718 | -0.076544 | down | 0.022084 | 1.528737 | 2007-10-09 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | |
AA_2007_Q3 | AA | null | null | 2,007 | 3 | 2007-10-09 17:00:00 | 2007-10-09 | Basic Materials | Executives:
Tony Thene - IR Alain Belda - Chairman & CEO Charles McLane - CFO
Analysts:
John Hill - Citigroup Kuni Chen - Banc of AmericaSecurities John Tumazos - Independent Research Anthony Rizzuto - Bear Stearns Charles Bradford - Bradford Research Michael Gambardella – JP Morgan Joshua Golden – JP Morgan ... | null | null | null | NONE | true | true | 0.043881 | -0.068043 | -0.211171 | 4,840,430.65 | 76.696028 | 77.014685 | 75.401496 | 76.277794 | 3,056,970 | 79.46435 | 79.74317 | 75.381597 | 77.134193 | 11,608,906 | 78.008741 | 78.708819 | 73.668251 | 75.328438 | 8,402,538 | 66.447468 | 67.107543 | 61.706938 | 62.006966 | 11,230,795 | bullish | 0.011227 | -0.012446 | -0.18709 | up | 0.041776 | 2.398321 | 2008-01-09 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2007_Q4 | AA | null | null | 2,007 | 4 | 2008-01-09 17:00:00 | 2008-01-09 | Basic Materials | Executives:
Tony Thene – Director of Investor Relations Alain Belda - Chairman and Chief Executive Officer Charles McLane – Executive Vice President and Chief Financial Officer
Analysts:
Kuni Chen - Banc of America Securities John Hill - Citi Oscar Cabrera - Goldman Sachs John Redstone – Desjardins Securities Charle... | null | null | null | NONE | true | true | -0.118065 | -0.144423 | -0.358753 | 4,340,004.25 | 66.447468 | 67.107543 | 61.706938 | 62.006966 | 11,230,795 | 63.167107 | 64.027202 | 61.906963 | 62.887077 | 12,058,843 | 65.689171 | 67.981354 | 65.085964 | 67.880821 | 4,465,834 | 77.793462 | 78.53742 | 76.305553 | 78.416779 | 5,799,625 | bullish | 0.014194 | 0.094729 | 0.264645 | up | 0.01871 | 2.778533 | 2008-04-07 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2008_Q1 | AA | null | null | 2,008 | 1 | 2008-04-07 05:00:00 | 2008-04-07 | Basic Materials | Executives:
Greg Aschman – Director, Investor Relations Alain Belda – Chairman & CEO Charles McLane – Executive VP & CFO Klaus Kleinfeld – President & COO
Analysts:
John Hill – Citigroup Michael Gambardella – J.P. Morgan Lloyd O’Carroll – Davenport & Co. Of Virginia, Inc. Harry Mateer – Lehman Brothers Charles Bradfor... | null | null | null | NONE | true | false | 0.07438 | 0.115334 | -0.18905 | 6,526,015.2 | 77.793462 | 78.53742 | 76.305553 | 78.416779 | 5,799,625 | 73.993309 | 75.662181 | 73.390108 | 74.75737 | 6,883,188 | 76.964684 | 78.015394 | 75.469438 | 76.964684 | 7,278,111 | 67.023321 | 69.791541 | 65.992813 | 67.46785 | 8,030,961 | bearish | -0.046666 | -0.018518 | -0.139625 | down | -0.05641 | 1.054731 | 2008-07-08 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2008_Q2 | AA | null | null | 2,008 | 2 | 2008-07-08 17:00:00 | 2008-07-08 | Basic Materials | Executives:
Greg Aschman - Director of Investor Relations Charles D. McLane Jr. - Chief Financial Officer, Executive Vice President Klaus Kleinfeld - President and Chief Executive Officer William F. Christopher - Executive Vice President; Group President - Engineered Products and Solutions
Analysts:
Michael Gambardell... | null | null | null | NONE | true | false | -0.181618 | -0.140066 | -0.302279 | 6,194,363.3 | 67.023321 | 69.791541 | 65.992813 | 67.46785 | 8,030,961 | 68.680184 | 68.902449 | 63.628685 | 63.729713 | 9,938,161 | 65.026764 | 65.859659 | 64.376701 | 64.600159 | 3,258,052 | 37.886556 | 38.597566 | 33.925229 | 36.789574 | 12,918,269 | very bearish | -0.055406 | -0.042505 | -0.45471 | down | 0.017969 | 1.604388 | 2008-10-07 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2008_Q3 | AA | null | null | 2,008 | 3 | 2008-10-07 17:00:00 | 2008-10-07 | Basic Materials | Executives:
Greg Aschman - Director of Investor Relations Charles D. McLane, Jr. - Chief Financial Officer, Executive Vice President Klaus Kleinfeld - President, Chief Executive Officer, Director
Analysts:
John Hill - Citigroup Michael Gambardella - J.P. Morgan Kuni Chen - Banc of America Securities David Lipschitz - ... | null | null | null | NONE | true | false | -0.438971 | -0.548655 | -0.593316 | 8,460,559.7 | 37.886556 | 38.597566 | 33.925229 | 36.789574 | 12,918,269 | 30.796788 | 31.467164 | 27.221433 | 29.882633 | 24,228,464 | 23.684572 | 24.137668 | 20.904208 | 21.130756 | 10,207,449 | 23.478612 | 23.643374 | 22.139921 | 22.263493 | 8,446,317 | very bearish | -0.187742 | -0.425632 | -0.394842 | down | -0.162894 | 2.863695 | 2009-01-12 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2008_Q4 | AA | null | null | 2,008 | 4 | 2009-01-12 17:00:00 | 2009-01-12 | Basic Materials | Executives:
Greg Aschman - Director of Investor Relations Charles D. McLane, Jr. - Chief Financial Officer, Executive Vice President Klaus Kleinfeld - President, Chief Executive Officer, Director
Analysts:
Kuni Chen - Banc of America Securities Jorge Beristain - Deutsche Bank Securities Michael Gambardella - J.P. Morg... | null | null | null | NONE | true | true | 0.114433 | -0.640203 | -0.753892 | 9,309,921.05 | 23.478612 | 23.643374 | 22.139921 | 22.263493 | 8,446,317 | 20.080391 | 20.554081 | 19.153604 | 19.668486 | 18,692,634 | 16.621722 | 16.705883 | 15.843235 | 16.200918 | 10,598,918 | 16.768991 | 16.832111 | 15.990505 | 16.64275 | 16,777,154 | very bearish | -0.116559 | -0.27231 | -0.252465 | down | -0.098057 | 2.007819 | 2009-04-07 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2009_Q1 | AA | null | null | 2,009 | 1 | 2009-04-07 17:00:00 | 2009-04-07 | Basic Materials | Executives:
Elizabeth Besen - Director of Investor Relations Charles D. McLane, Jr. - Chief Financial Officer, Executive Vice President Klaus Kleinfeld - President, Chief Executive Officer, Director
Analysts:
Kuni Chen - Banc of America/Merrill Lynch Mark Liinamaa - Morgan Stanley Charles Bradford – Bradford Research ... | null | null | null | NONE | true | true | 0.361445 | -0.116846 | -0.816026 | 27,030,295.5 | 16.768991 | 16.832111 | 15.990505 | 16.64275 | 16,777,154 | 16.979405 | 17.168767 | 15.780116 | 16.958364 | 31,353,766 | 23.086297 | 23.170707 | 20.047516 | 20.786108 | 23,614,732 | 19.752081 | 20.490673 | 19.58326 | 20.38516 | 11,926,425 | bullish | 0.018964 | 0.248959 | 0.224867 | up | 0.020228 | 1.159949 | 2009-07-14 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2009_Q2 | AA | null | null | 2,009 | 2 | 2009-07-14 17:00:00 | 2009-07-14 | Basic Materials | Executives:
Matthew Garth - Director of Investor Relations Charles D. McLane, Jr. - Chief Financial Officer, Executive Vice President Klaus Kleinfeld - President, Chief Executive Officer, Director
Analysts:
Mark Liinamaa - Morgan Stanley Charles Bradford – Bradford Research Sal Tharani – Goldman Sachs Brian Yu - Citi... | null | null | null | NONE | true | true | 0.047722 | 0.552675 | -0.717087 | 17,623,037.85 | 19.752081 | 20.490673 | 19.58326 | 20.38516 | 11,926,425 | 20.722801 | 21.419188 | 20.490672 | 21.398087 | 14,654,474 | 28.153409 | 29.084098 | 27.75152 | 28.999491 | 15,589,263 | 34.899023 | 36.086353 | 34.877822 | 36.086353 | 13,835,289 | bullish | 0.049689 | 0.422578 | 0.770227 | up | 0.016563 | 0.831552 | 2010-01-11 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2009_Q4 | AA | null | null | 2,009 | 4 | 2010-01-11 17:00:00 | 2010-01-11 | Basic Materials | Executives:
Matthew Garth – Director Investor Relations Charles D. McLane Jr. – Chief Financial Officer Klaus Kleinfeld – Executive Vice President, Chief Executive Officer
Analysts:
Jorge Beristain – Deutsche Bank Michael Gambardella – J.P. Morgan David Gagliano – Credit Suisse Mark Liinamaa – Morgan Stanley Sal Thara... | null | null | null | NONE | true | true | 0.317338 | 0.415804 | -0.002344 | 13,330,079.05 | 34.899023 | 36.086353 | 34.877822 | 36.086353 | 13,835,289 | 34.178121 | 34.453754 | 32.693961 | 32.905983 | 64,876,654 | 28.282339 | 28.346084 | 27.623621 | 27.963604 | 13,753,267 | 31.235948 | 31.320943 | 30.152253 | 30.57723 | 23,392,301 | very bearish | -0.088132 | -0.225092 | -0.152665 | down | -0.05288 | 4.866937 | 2010-04-12 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2010_Q1 | AA | null | null | 2,010 | 1 | 2010-04-12 17:00:00 | 2010-04-12 | Basic Materials | Executives:
Matthew Garth – Director Investor Relations Charles D. McLane Jr. – Chief Financial Officer Klaus Kleinfeld – Executive Vice President, Chief Executive Officer
Analysts:
Mark Liinamaa – Morgan Stanley Michael Gambardella – J.P. Morgan Sal Tharani – Goldman Sachs Curt Woodworth – Macquarie Capital John Red... | null | null | null | NONE | true | true | 0.081142 | 0.139151 | -0.180588 | 14,954,629.65 | 31.235948 | 31.320943 | 30.152253 | 30.57723 | 23,392,301 | 30.385989 | 30.57723 | 29.876013 | 30.470984 | 41,902,538 | 25.985682 | 26.709872 | 25.900483 | 26.539474 | 12,992,176 | 23.429707 | 23.429707 | 22.748115 | 23.152809 | 16,272,784 | neutral | -0.003475 | -0.132051 | -0.242809 | down | -0.006254 | 2.801978 | 2010-07-13 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2010_Q2 | AA | null | null | 2,010 | 2 | 2010-07-13 17:00:00 | 2010-07-13 | Basic Materials | Executives:
Matthew Garth – Director, IR Chuck McLane – EVP and CFO Klaus Kleinfeld – Chairman and CEO
Analysts:
Kuni Chen – BofA/Merrill Lynch Sal Tharani – Goldman Sachs Curt Woodworth – JPMorgan Tony Rizzuto – Dahlman Rose Pertash Misra [ph] Charles Bradford – Affiliated Research Group Jorge Beristain – Deutsche Ba... | null | null | null | NONE | true | true | -0.080373 | -0.18321 | -0.379548 | 11,411,670.75 | 23.429707 | 23.429707 | 22.748115 | 23.152809 | 16,272,784 | 23.451009 | 23.664007 | 23.046314 | 23.238012 | 10,752,060 | 22.615111 | 23.277121 | 22.35885 | 22.914083 | 8,101,748 | 25.967873 | 26.629883 | 25.839742 | 26.41633 | 11,697,628 | neutral | 0.00368 | -0.010311 | 0.140956 | up | 0.01288 | 0.942199 | 2010-10-07 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2010_Q3 | AA | null | null | 2,010 | 3 | 2010-10-07 17:00:00 | 2010-10-07 | Basic Materials | Executives:
Matthew Garth – Director, IR Chuck McLane – EVP and CFO Klaus Kleinfeld – Chairman and CEO
Analysts:
Curt Woodworth – Macquarie Brian Yu – Citi Mark Liinamaa – Morgan Stanley Jorge Beristain – Deutsche Bank Sal Tharani – Goldman Sachs David Gagliano – Credit Suisse Charles Bradford – Affiliated Research Gr... | null | null | null | NONE | true | true | 0.229622 | 0.06548 | -0.292092 | 11,096,108.95 | 25.967873 | 26.629883 | 25.839742 | 26.41633 | 11,697,628 | 26.907494 | 28.039318 | 26.907494 | 27.526794 | 30,284,436 | 29.751081 | 29.943714 | 29.408623 | 29.879503 | 9,425,343 | 35.209009 | 35.251818 | 34.459882 | 35.144798 | 15,107,158 | bullish | 0.042037 | 0.1311 | 0.330419 | up | 0.018593 | 2.729284 | 2011-01-10 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2010_Q4 | AA | null | null | 2,010 | 4 | 2011-01-10 17:00:00 | 2011-01-10 | Basic Materials | Executives:
Roy Harvey – Director, Investor Relations Klaus Kleinfeld – Chairman and CEO Chuck McLane – Executive Vice President and CFO
Analysts:
Curt Woodworth – Macquarie Sal Tharani – Goldman Sachs Mark Liinamaa – Morgan Stanley David Gagliano – Credit Suisse John Redstone – Desjardins Tony Rizzuto – Dahlman Rose ... | null | null | null | NONE | true | true | 0.233659 | 0.610303 | -0.058186 | 10,772,646.65 | 35.209009 | 35.251818 | 34.459882 | 35.144798 | 15,107,158 | 34.845136 | 35.230403 | 34.459873 | 34.952156 | 30,137,120 | 36.899595 | 37.135445 | 36.556542 | 36.792393 | 10,421,806 | 39.2152 | 39.601135 | 38.057398 | 38.42189 | 12,199,001 | neutral | -0.005481 | 0.04688 | 0.093245 | down | -0.008526 | 2.79756 | 2011-04-11 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2011_Q1 | AA | null | null | 2,011 | 1 | 2011-04-11 17:00:00 | 2011-04-11 | Basic Materials | Executives:
Roy Harvey - Director of Investor Relations Klaus Kleinfeld - Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Chairman of International Committee Charles McLane - Chief Financial Officer and Executive Vice President
Analysts:
Anthony Rizzuto - Dahlman Rose & Company, LLC P... | null | null | null | NONE | true | true | 0.07434 | 0.367181 | -0.029778 | 9,532,509.35 | 39.2152 | 39.601135 | 38.057398 | 38.42189 | 12,199,001 | 36.256368 | 36.663742 | 35.441615 | 35.80611 | 33,834,166 | 37.371299 | 37.457064 | 36.449347 | 36.556549 | 11,229,213 | 34.902702 | 35.2034 | 34.623477 | 35.181923 | 8,062,422 | very bearish | -0.06808 | -0.048549 | -0.084326 | down | -0.056362 | 3.549345 | 2011-07-11 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2011_Q2 | AA | null | null | 2,011 | 2 | 2011-07-11 17:00:00 | 2011-07-11 | Basic Materials | Executives:
Klaus Kleinfeld - Chairman of the Board, Chief Executive Officer, President, Chairman of Executive Committee and Chairman of International Committee Roy Harvey - Director of Investor Relations Charles McLane - Chief Financial Officer and Executive Vice President
Analysts:
Jorge Beristain - Deutsche Bank AG... | null | null | null | NONE | true | true | 0.003062 | 0.011021 | -0.111593 | 8,332,386.65 | 34.902702 | 35.2034 | 34.623477 | 35.181923 | 8,062,422 | 33.914693 | 34.580529 | 33.721385 | 33.742863 | 14,231,253 | 25.850547 | 26.022742 | 24.83891 | 24.968056 | 15,514,482 | 21.588758 | 21.782474 | 21.330467 | 21.717901 | 12,314,524 | bearish | -0.040903 | -0.290316 | -0.382697 | down | -0.036019 | 1.707944 | 2011-10-11 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2011_Q3 | AA | null | null | 2,011 | 3 | 2011-10-11 17:00:00 | 2011-10-11 | Basic Materials | Executives:
Klaus Kleinfeld - Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of International Committee Roy Harvey - Director of Investor Relations Charles D. McLane - Chief Financial Officer and Executive Vice President
Analysts:
Jorge M. Beristain - Deutsche Bank AG, Research Divisio... | null | null | null | NONE | true | true | -0.149241 | -0.375838 | -0.451584 | 15,103,287.6 | 21.588758 | 21.782474 | 21.330467 | 21.717901 | 12,314,524 | 21.373517 | 22.191435 | 20.943033 | 21.631807 | 45,699,667 | 22.341983 | 22.471503 | 21.867082 | 22.12612 | 9,540,616 | 19.600498 | 19.967468 | 19.600498 | 19.77319 | 14,641,282 | neutral | -0.003964 | 0.018796 | -0.089544 | down | -0.015857 | 3.025809 | 2012-01-09 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2011_Q4 | AA | null | null | 2,011 | 4 | 2012-01-09 17:00:00 | 2012-01-09 | Basic Materials | Executives:
Klaus Kleinfeld - Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of International Committee Charles D. McLane - Chief Financial Officer and Executive Vice President Kelly Pasterick - Director of Investor Relations
Analysts:
Brian Yu - Citigroup Inc, Research Division Pareto... | null | null | null | NONE | true | true | -0.010799 | -0.260346 | -0.500691 | 12,488,645.5 | 19.600498 | 19.967468 | 19.600498 | 19.77319 | 14,641,282 | 20.938866 | 21.262663 | 20.2481 | 20.377619 | 26,715,897 | 23.274168 | 23.642225 | 22.971063 | 23.100965 | 11,233,417 | 20.589515 | 21.044174 | 20.481263 | 20.784369 | 9,854,224 | bullish | 0.030568 | 0.168297 | 0.051139 | up | 0.058952 | 2.139215 | 2012-04-10 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2012_Q1 | AA | null | null | 2,012 | 1 | 2012-04-10 17:00:00 | 2012-04-10 | Basic Materials | Executives:
Kelly Pasterick - Director of Investor Relations Charles D. McLane - Chief Financial Officer and Executive Vice President Klaus Kleinfeld - Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of International Committee
Analysts:
Michael F. Gambardella - JP Morgan Chase & Co, Res... | null | null | null | NONE | true | true | -0.079578 | 0.017805 | -0.475157 | 10,310,851 | 20.589515 | 21.044174 | 20.481263 | 20.784369 | 9,854,224 | 21.520484 | 21.975141 | 21.390581 | 21.433882 | 33,245,693 | 20.049037 | 20.092482 | 19.614605 | 19.766657 | 7,425,468 | 19.093289 | 19.093289 | 18.702301 | 18.962959 | 10,496,005 | bullish | 0.03125 | -0.048965 | -0.087634 | up | 0.035417 | 3.22434 | 2012-07-09 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2012_Q2 | AA | null | null | 2,012 | 2 | 2012-07-09 17:00:00 | 2012-07-09 | Basic Materials | Executives:
Kelly Pasterick - Director of Investor Relations Charles D. McLane - Chief Financial Officer and Executive Vice President Klaus-Christian Kleinfeld - Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of International Committee
Analysts:
Jorge M. Beristain - Deutsche Bank AG, R... | null | null | null | NONE | true | true | 0.013937 | -0.155379 | -0.461332 | 8,366,731.1 | 19.093289 | 19.093289 | 18.702301 | 18.962959 | 10,496,005 | 19.158457 | 19.288787 | 18.115819 | 18.246149 | 23,783,354 | 18.637981 | 19.182951 | 18.550785 | 19.182951 | 8,831,669 | 19.662525 | 20.098501 | 19.618928 | 19.880512 | 5,931,045 | bearish | -0.037801 | 0.011601 | 0.048387 | down | 0.010309 | 2.84261 | 2012-10-09 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2012_Q3 | AA | null | null | 2,012 | 3 | 2012-10-09 17:00:00 | 2012-10-09 | Basic Materials | Executives:
Kelly Pasterick – Director-Investment Relations Charles D. McLane Jr. – Executive Vice President and Chief Financial Officer Klaus Kleinfeld – Chairman and Chief Executive Officer
Analysts:
David Gagliano – Barclays Capital Paretosh Misra – Morgan Stanley David Lipschitz – Credit Agricole Securities Carly ... | null | null | null | NONE | true | false | 0.056779 | 0.070458 | -0.207859 | 8,302,263.85 | 19.662525 | 20.098501 | 19.618928 | 19.880512 | 5,931,045 | 19.727923 | 19.749721 | 18.877769 | 18.986763 | 20,046,525 | 18.571602 | 18.724723 | 18.155983 | 18.352854 | 7,733,541 | 20.299699 | 20.321573 | 19.905954 | 19.905954 | 9,065,751 | bearish | -0.044956 | -0.076842 | 0.00128 | down | -0.007675 | 2.414585 | 2013-01-08 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2012_Q4 | AA | null | null | 2,012 | 4 | 2013-01-08 17:00:00 | 2013-01-08 | Basic Materials | Executives:
Klaus Kleinfeld – Chairman and CEO Charles D. McLane Jr. – EVP and CFO Kelly Pasterick – Director of IR
Analysts:
Curt Woodworth – Nomura Michael Gambardella – JPMorgan Harry Mateer - Barclays Capital Carly Mattson - Goldman Sachs & Company Timna Tanners – Bank of America Merrill Lynch Jorge Beristain - De... | null | null | null | NONE | false | false | 0.100362 | 0.058131 | -0.158034 | 6,853,997.15 | 20.299699 | 20.321573 | 19.905954 | 19.905954 | 9,065,751 | 20.409074 | 20.409074 | 19.818457 | 19.862207 | 17,390,470 | 19.621806 | 19.687651 | 19.468167 | 19.534012 | 5,946,067 | 17.86594 | 18.195166 | 17.800097 | 18.085424 | 10,085,851 | neutral | -0.002198 | -0.018685 | -0.091457 | down | 0.025275 | 2.537274 | 2013-04-08 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
AA_2013_Q1 | AA | null | null | 2,013 | 1 | 2013-04-08 17:00:00 | 2013-04-08 | Basic Materials | Executives:
Klaus Kleinfeld - Chairman and Chief Executive Officer William Oplinger - Executive Vice President and Chief Financial Officer
Analysts:
Brian Yu - Citigroup Michael Gambardella - JPMorgan Sal Tharani - Goldman Sachs Timna Tanners - Bank of America Merrill Lynch David Gagliano - Barclays Capital Tony Rizzu... | null | null | null | NONE | true | true | -0.048499 | -0.009851 | -0.184239 | 6,394,819 | 17.86594 | 18.195166 | 17.800097 | 18.085424 | 10,085,851 | 18.217114 | 18.656081 | 18.173217 | 18.414648 | 17,315,273 | 18.985298 | 19.49011 | 18.985298 | 19.468161 | 8,703,829 | 17.111727 | 17.199818 | 16.869477 | 17.199818 | 6,199,334 | bullish | 0.018204 | 0.076456 | -0.048968 | up | 0.007282 | 2.707703 | 2013-07-08 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.